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Abstract 
The present study investigated the exercise-induced salivary hormonal (cortisol and 
testosterone) and mucosal immunological (salivary secretory immunoglobulin A (SIgA)) 
responses to a 30 min high-intensity running bout (RPEtreadmill) before and after (~1 day and 6 
days after) a 12 day intensified training period. Eight active males completed the study. 
Unstimulated saliva samples were collected pre-exercise, post-exercise and 30 min post-
exercise and assessed for salivary cortisol, testosterone and SIgA. 10 km TT performance 
decreased by 3% from pre- to post-training (ES = 0.24). The exercise-induced salivary 
testosterone response significantly elevated by 36% pre-training and decreased by 42% post-
training (ES = 0.43). Salivary cortisol and SIgA responses were unaffected by the exercise 
and training, although a small ES between pre- and post-training were observed (0.32-0.49). 
Four participants completed a post-recovery trial and salivary cortisol, testosterone, SIgA 
responses were unaffected by the exercise and training, although a small to large ES between 
pre-training, post-training and post-recovery were observed (0.4-1.24). Individual results are 
presented for four participants and two were identified as showing signs of overreaching. 
This study demonstrates that the RPEtreadmill bout induces robust elevations in salivary 
testosterone and can potentially highlight any alterations in this hormone following a 12 day 
intensified training period.  
 
Key words: salivary testosterone, salivary cortisol, salivary secretory immunoglobulin A, 
overreaching, intensified training  
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80% Ẇmax 
60/90 30 min continuous cycle consisting of 1 min blocks at 60% Ẇmax and 
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CHAPTER 1 Introduction 
Optimising physical performance is a fundamental aim for athletes to achieve during a 
competitive season (Mujika, 2010). To elicit this, carefully planned training programmes are 
designed in order to achieve peak performance that coincide with competition days to 
maximise the potential for success (Borresen and Lambert, 2009). Therefore, training 
periodisation is commonly used to structure and plan training and includes phases of 
insufficient training, competitive training, active rest and tapering (Plisk and Stone, 2003). 
The two most important components of a successful training programme are the training 
stress (intensity, frequency and volume) and recovery. Increasing the training stress and 
incorporating this with sufficient recovery induces positive physiological adaptations such as 
muscle hypertrophy to occur and therefore may help to improve the athlete’s physical 
performance (Armstrong and VanHeest, 2002). However, an imbalance between the training 
stress and the recovery increases the likelihood of injury and possibly lead to the overtraining 
syndrome (OTS) resulting in chronic maladaptation’s and performance decrements (which 
may never fully recover to baseline) (Meeusen et al., 2013).  
Overreaching and the OTS are viewed on a continuum from acute fatigue (short-term 
recovery) to chronic fatigue (long-term recovery) as a result of intensified training overload 
(Figure 1). Short-term overreaching is defined as functional overreaching (FOR) which 
occurs in the acute stages of fatigue. When the training intensity is increased, the recovery 
time becomes longer in duration resulting in long-term overreaching defined as non-
functional overreaching (NFOR) (Meeusen et al., 2013). Additional intensified training 
without inadequate recovery prolongs the recovery process further and can move into an 
extreme state of fatigue defined as the OTS (Meeusen et al., 2013). It has been suggested that 
signs of overreaching can occur within a period as short as 7 days of intensified training with 
limited recovery (Halson et al., 2002). Symptoms of overreaching and the OTS also include 
prolonged fatigue, psychological and hormonal disturbances (Hooper, Mackinnon and 
Hanrahan, 1997), loss of motivation (Meeusen et al., 2013), loss of appetite, unexplained 
weight loss and sleep disturbances (Armstrong and VanHeest, 2002). These symptoms of 
overreaching are common in elite athletes with studies showing prevalence rates of up to 64% 
and career rates of up to 33% in non-elite athletes (Birrer et al., 2013). The prevalence rate of 
the OTS is less common due to retrospective diagnosis however the severity of OTS is still a 
problem for athletes as many who have developed OTS are at a heightened risk of relapsing 
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(Meeusen et al., 2013). Therefore, the importance of preventing overreaching (leading to the 
OTS) occurring is crucial for athletes as prolonged periods of these symptoms can interfere 
with optimal preparation for major competitions (MacKinnon, 2000).  
 
 
Figure 1 Schematic representation of overreaching (FOR and NFOR) and the overtraining syndrome (OTS) 
continuum (adapted from Meeusen et al. (2013)). 
 
Currently there is no biological marker available to diagnose and aid in the prevention of 
overreaching and therefore establishing a reliable detection method is both useful and 
required (Meeusen et al., 2013). The most recent position statement from the European 
College of Sport Science and American College of Sports Medicine on OTS has outlined a 
number of key ingredients of a reliable biological marker (Meeusen et al., 2013). Firstly, a 
reliable biological marker should be sensitive to the training load without being affected by 
other factors such as diet and chronobiological rhythms. Changes in the marker should occur 
before the onset of OTS as well as being able to distinguish between acute and chronic 
responses to exercise. Inexpensive, non-invasive and ease of measurement with quick 
availability of results are also key ingredients to consider. Finally, obtaining the marker 
should be from rest or submaximal exercise of relatively short-duration so it does not disrupt 
an athlete’s training programme (Meeusen et al., 2013). Establishing a reliable biomarker of 
overreaching would therefore help to predict/monitor athletes prospectively for the   
incidence of the OTS. Many markers have been suggested and these include hormonal 
alterations (Duclos, 2008), performance measures (Meeusen et al., 2004) and immunological 
alterations (Halson and Jeukendrup, 2004; Kreher, 2016). However, to date, none of these 
Intensified training (overload) 
 Temporary performance 
decrement 
 Days-weeks to recover 
 
 Stagnated performance 
decrement 
 Weeks-months to 
recover 
 Performance decrease 
 Months-years to 
recover (full recovery 
may never occur) 
 
Functional 
overreaching (FOR) 
Non-functional 
overreaching (NFOR) 
Overtraining 
syndrome (OTS) 
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markers have been shown to provide sufficient sensitivity and reliability to be used as a 
diagnostic test of overreaching. 
Hormonal alterations of cortisol and testosterone have been highlighted as potential 
indicators of overreaching and the OTS (Duclos, 2008). These hormones have previously 
been examined in relation to overreaching and the OTS as they have been shown to be 
indicative of stress and recovery in response to exercise leading to disruptions in the 
hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-gonadal (HPG) axis 
(Kreher, 2016). Early research extensively investigated the resting concentrations of 
testosterone/cortisol ratio concluding that the use of both hormones as definitive markers of 
the OTS are equivocal with no clear and consistent alteration in these markers to highlight a 
state of overreaching (Meeusen et al., 2013). Due to the disparity in the literature regarding 
the usefulness of using resting measures of cortisol and testosterone to highlight 
overreaching/OTS, the examination of the exercise-induced hormonal alterations of cortisol 
and testosterone responses during an overreached state has recently been investigated 
(Meeusen et al., 2004, 2010; Hough et al., 2011, 2013; Hough, Robertson and Gleeson, 
2015). These studies have shown encouraging results and may provide a useful measure to 
highlight a state of overreaching. However, only a limited amount of research is available that 
addresses this research area. 
Other markers of overreaching and the OTS have been investigated, specifically 
immunological responses due to alterations in immunological function of athletes when 
training excessively (Kreher, 2016). Periods of intensified training (leading to overreaching 
and the OTS) creates an “open window” for illnesses such as upper respiratory symptoms 
(URS) (Halson and Jeukendrup, 2004; Meeusen et al., 2013). In accordance with the latest 
Position Statement on Immune Function and Exercise, URS is now the accepted term to use 
in exercise studies rather than upper respiratory tract infections (URTI) (Walsh et al., 2011). 
Although URTI are the most common reason for the appearance in athletes, recent evidence 
has suggested that not all URTI that occur in response to training are due to an “open 
window” of impaired immunity. Therefore, there is evidence to suggest other hypotheses for 
non-infectious causes of URS (i.e. airway inflammation, allergy and autoimmune disorders) 
(Helenius, Lumme and Haahtela, 2005; Cox et al., 2008). Furthermore, URTI are verified by 
physician confirmation and this has come under scrutiny and been found to be less ideal (Cox 
et al., 2008).  
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The “open window” hypothesis proposes that between 3 and 72 h after intensive exercise, 
athletes are susceptible to illness (Pedersen and Ullum, 1994). Many researchers have 
expanded on this hypothesis suggesting that athletes who engage in excessive amounts of 
intensive exercise without a sufficient recovery period show a cumulative effect of the “open 
window”. In principle, this chronically alters the immune function of athletes and could 
therefore explain the immunosuppression in overreaching athletes and athletes with OTS 
(Mackinnon, 1999; Smith, 2003). This phenomenon has been modelled in the form of a J-
shaped curve which suggests that moderate levels of exercise reduces the risk of URS while 
chronic levels of exercise increases the risk of URS (Nieman, 1994b, 1994a). Subsequently, 
research has focused its attention on the mucosal immune system as it has been reported that 
95% of all reported URS are originated from the mucosal surfaces (Bosch et al., 2002). In 
particular, salivary secretory immunoglobulin A (SIgA) is used as the primary marker of the 
mucosal immune system as the majority of immunoglobulins are expressed in mucosal fluids 
(MacKinnon, 2000; Owen et al., 2016). SIgA is the only immunological marker that 
consistently shows an association with URS (Gleeson, 2000; Bishop and Gleeson, 2009; 
Shephard, 2010).  
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CHAPTER 2 Literature Review 
This chapter will describe the notion of overreaching and the OTS and specifically review the 
hormonal (cortisol and testosterone) and immunological (SIgA) markers of overreaching. 
This chapter will then review the current literature on the cortisol and testosterone responses 
to acute exercise and periods of intensified training. Moreover, a review of the literature on 
the SIgA responses to acute exercise and periods of intensified training will follow. 
 
2.1 Overreaching and the Overtraining Syndrome 
For athletes to develop and improve their performance, a successful training programme must 
include overload and recovery (Borresen and Lambert, 2009). Therefore, an imbalance 
between the two needs to be avoided to ensure that an abnormal training response does not 
occur (Meeusen et al., 2013).  Athletes will commonly increase the intensity and/or volume 
of the training in order to enhance performance (Mujika, 2010). Consequently, acute feelings 
of fatigue may be experienced as a result of a single intense training session or intense 
training period. Athletes will progressively overload the body by increasing the intensity 
and/or volume of training, which is likely to cause the athlete to underperform for a limited 
period of time (days to weeks). But with sufficient recovery, the athlete will return or 
experience a super-compensatory effect where performance is enhanced beyond baseline 
levels. This phenomenon is known as functional overreaching (FOR) (Meeusen et al., 2013). 
This is what coaches would strive to achieve to improve an athletes performance (Halson, 
2014). However, if an athlete continues to complete an intensified training load without 
completing appropriate recovery then they move into a state of overreaching known as non-
functional overreaching (NFOR) (Meeusen et al., 2013). Recovery from this state may take 
weeks to months to complete (Meeusen et al., 2013). In extreme cases where inadequate 
recovery is incorporated, there is potential for OTS to develop and this could take months or 
years for full recovery from this syndrome.  It is also possible that full recovery never occurs 
(Meeusen et al., 2010). However, much of the literature reviewed shows that NFOR and OTS 
is very difficult to distinguish between as athletes will often show similar signs and 
symptoms of performance decrement and hormonal and psychological disturbances 
(Meeusen et al., 2004). More importantly, the main difference is the duration of time it takes 
for full recovery to occur from underperformance (i.e. FOR, days to weeks, NFOR, weeks to 
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months and OTS, months to years) and this may not occur at all if an athlete is suffering from 
OTS (Meeusen et al., 2010). The term “prolonged maladaptation” of biological, 
neurochemical and hormonal regulation mechanisms may be useful in diagnosing athletes 
with OTS (Meeusen et al., 2013). Also, the subtle difference between NFOR and OTS is 
made more complicated by the fact that clinical features are individualised and are 
nonspecific, anecdotal and numerous (Meeusen et al., 2013). 
 
2.2 Markers of Overreaching – Hormone Responses 
As no definitive marker has been established to diagnose athletes with FOR, NFOR and OTS, 
the need for establishing a biological marker of overreaching specifically is necessary. This 
will help reduce the incidences of OTS if the measurement is understood and acted upon by 
coaches and athletes. The literature suggests that cortisol (catabolic in nature) and 
testosterone (anabolic in nature) can be indicative of a state of stress and recovery 
respectively (Duclos, 2008). The foundation of the research in this area suggested that resting 
plasma testosterone/cortisol ratios were considered as an indicator of overreaching (Meeusen 
et al., 2013). It was thought that the testosterone/cortisol ratio decreases in response to the 
intensity and duration of training and therefore being indicative of an overreached (FOR or 
NFOR) state. However, recent literature has shown this not to be a true indication of 
overreaching/OTS as evidence shows that the testosterone/cortisol ratio only indicates the 
actual physiological strain of exercise (Duclos, 2008). Urhausen, Gabriel and Kindermann 
(1998) investigated the hormonal responses in 17 male endurance athletes prior to and during 
a state of short-term overtraining over a period of ~19 months. They found that resting 
testosterone/cortisol ratios did not significantly change between normally trained (i.e. 
healthy) and overtrained athletes (defined as decrease in performance and early fatigue) 
(cortisol 254 ± 19 vs 264 ± 28 nmol·L
-1
; testosterone 17.2 ± 1.5 vs 18.4 ± 2.2 pmol·L
-1
). 
However, a moderate effect size (ES) for testosterone was observed which does highlight that 
a difference between normally trained and overtrained athletes did occur but were not 
identified as significant due to a lack of power of the study. Similarly, Mackinnon et al., 
(1997) using 24 elite swimmers observed no significant difference in the resting plasma 
testosterone/cortisol ratio between overreached and well-trained athletes following a 4 week 
intensified training period. Supplementary studies have also observed no changes in the 
resting testosterone/cortisol ratios which further highlights that this marker may be incapable 
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of identifying athletes in an overreached state (Flynn et al., 1994; Hooper et al., 1995). In 
these studies, participants were classified as overreached if they displayed decreases in 
performance and persistent feelings of fatigue. Therefore, the use of the testosterone/cortisol 
ratio as a marker to evaluate overreaching in these subjects was found to be inconsistent.  
It is clear from previous studies that the resting testosterone/cortisol ratio as a marker of 
overreaching and OTS is not reliable and also highlights that this ratio cannot distinguish 
between NFOR, FOR and OTS. Furthermore, it is evident in endurance athletes who have a 
normal 24 h cortisol secretion during rest (Duclos, Gouarne and Bonnemaison, 2003), 
morning plasma cortisol concentrations and 24 h urinary cortisol excretion is similar to those 
of similar aged sedentary subjects (Duclos et al., 1997). Furthermore, they also maintain a 
seasonal rhythmicity of cortisol excretion similar to sedentary men (Meeusen et al., 2006). 
Many of the studies investigating hormonal responses highlights the variation of methods 
used suggesting that diagnosing athletes with overreaching or OTS is difficult due to pre-
analytical factors such as sample timing, food intake, gender, age and also other hormones 
which are under a feedback control (Meeusen et al., 2013). Therefore, a consensus in the 
literature suggests that overreaching and the OTS must be viewed on a continuum with a 
disturbance, an adaptation, and maladaptation of the HPA and HPG axes (Urhausen, Gabriel 
and Kindermann, 1998; Meeusen et al., 2004; Kreher, 2016).  
In recent years, some attention has been given to examining the exercise-induced hormone 
responses as this may provide a better understanding of neuroendocrine imbalances that occur 
during an overreached state (Meeusen et al., 2004, 2010). Meeusen et al. (2004) developed a 
test protocol involving two consecutive maximal incremental exercise tests separated by 4 h. 
Using seven well-trained cyclists, a state of overreaching was induced during a training camp 
(10 day training camp including an increase in training volume of 58% from a normal 
training volume). Meeusen and colleagues found that cycling performance (time to volitional 
exhaustion) had decreased by 6% between first and second exercise tests in the overreached 
group and there was also a blunted cortisol and adrenocorticotrophic hormone (ACTH) 
response following the 10 day training period compared with athletes who were in a normal 
trained state. This study suggests that endocrine responses are altered to short-duration and 
high-intensity exercise while in an overreached state. A follow up to the previous study was 
conducted investigating whether a distinction between NFOR and the OTS could be made 
(Meeusen et al., 2010). It was expected that the cortisol response is less pronounced in a FOR 
stage and significantly blunted in a NFOR stage whereas individuals with the OTS would be 
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expected to have complete cortisol suppression (Meeusen et al., 2004). Using the same two-
bout protocol, they found that cortisol responses were good markers for OTS but were much 
less sensitive to distinguish between NFOR and OTS. The two-bout cycling protocol has 
shown positive results and could be used as a tool to diagnose overreaching and OTS, 
however, the two exercise tests separated by 4 h could be influenced by diurnal variation of 
the hormones and also bouts are very long in duration (i.e. 6 h to complete). Therefore, a 
single short-duration, high-intensity exercise test would be more useful due to the simple 
practicality of completing a shorter test (i.e. 30 min) compared to completing two 40 min 
tests separated by 4 h. 
A continuous 30 min high-intensity cycling bout, compromising of alternating blocks of 1 
min at 55% maximum work rate (Ẇmax) and 4 min at 80% Ẇmax (55/80) has been developed 
(Hough et al., 2011). It was found that plasma and salivary cortisol and testosterone 
concentrations were increased in normally trained individuals, and therefore highlighting that 
these hormones elevate when not in an overreached state. The 55/80 protocol could possibly 
be used as a tool to identify and prevent overreaching and OTS occurring in athletes and this 
has been shown in a more recent study (Hough et al., 2013). Using the same 55/80 protocol, a 
decreased exercise-induced salivary cortisol (11.1 to 3.1 nmol·L
-1
; 72% decrease), 
testosterone (407 to 258 pmol·L
-1
; 37% decrease) response and testosterone/cortisol ratio (12 
to 4; 67% decrease) occurred following an 11 day endurance training period. The findings 
from this study suggest that overreached individuals (and possible individuals suffering from 
the OTS) have a blunted cortisol and testosterone response. Despite the development of a 
useful tool to highlight the hormonal alterations in overreached individuals, this may only be 
useful in a group familiar with cycling (i.e. cyclists). Therefore, it may be beneficial to 
develop a similar tool that would be applicable to runners.  
The University of Bedfordshire laboratories has therefore developed a short-duration (30 
min), high-intensity running test known as the RPEtreadmill. This running test consists of 30 
min continuous running alternating between blocks of 1 min at 11 (fairly light) on the 6 – 20 
Borg rating of perceived exertion (RPE) scale and 4 min at 15 (hard) on the Borg scale. This 
protocol has been shown to elicit reproducible exercise-induced elevations of plasma and 
salivary cortisol and testosterone when in a normal trained state (Leal, 2017). They reported a 
42% elevation in plasma cortisol as well as a 64% elevation in salivary cortisol from pre- to 
post-exercise. They also found that plasma and salivary testosterone elevated by 42% from 
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pre- to post-exercise. This protocol could therefore highlight any blunted cortisol and 
testosterone responses that may occur when in an overreached state. 
 
2.2.1 Cortisol and the Hypothalamic-Pituitary-Adrenal Axis 
Stress is an innate response to survival in order to maintain homeostasis, thus the endocrine, 
nervous and immune systems are activated (Smith and Vale, 2006). The HPA axis is an 
essential component in responding to stressful stimuli which are internal or external in nature 
(Chrousos, 1995). The regulation of the HPA axis is dependent upon negative feedback 
mechanisms (Tsigos and Chrousos, 2002). The pathway originates with synthesis and 
secretion of corticotrophin-releasing hormone (CRH) from neurons within the paraventricular 
nuclei (PVN) of the hypothalamus (Chrousos, 1995). During a state of rest, the body 
continuously releases CRH into the hypophyseal portal system throughout the day with 
secretion episodes occurring two to three times per hour (Engler et al., 1989). The 
hypophyseal portal system is a blood portal system consisting of blood vessels which links 
the hypothalamus to the pituitary gland (Capen, 2001). In response to stressors such as 
exercise, CRH production is significantly increased into the hypophyseal portal system that 
accesses the anterior pituitary gland. Within the anterior pituitary gland, CRH binds together 
to its respective cognate transmembrane receptors which trigger the release of ACTH and is 
secreted into circulatory system (Smith and Vale, 2006). ACTH travels and causes it’s action 
in the adrenal glands (specifically the adrenal cortex) stimulating the secretion of cortisol 
located in the zona fasciculate (Smith and Vale, 2006; Nicolaides et al., 2014). The zona 
fasciculate is one of three sections which make up the adrenal cortex; the other two are 
known as the zona glomerulosa and zona reticularis (Sayers, 1950).  
Cortisol is the main glucocorticoid in humans which acts as the final hormonal product in the 
HPA axis pathway (Turnball and Rivier, 1999) where approximately 75% of total cortisol is 
bound to cortisol-binding globulin (CBG) and 15% to albumin within the blood (Kraemer 
and Ratamess, 2005). The remainder represents the biologically active fraction of free 
cortisol which is not bound to CBG (Duplessis et al., 2010) and has been suggested to reflect 
the HPA reserve more accurately (Torpy and Ho, 2007). The biological active fraction 
enables cortisol to be readily available for tissue uptake (Pardridge, 1986). The unbound 
serum (free) cortisol is important as it enters the saliva via intracellular mechanisms. The 
majority of cortisol within the saliva remains free from bounding proteins.  
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Salivary cortisol has been shown to have positive correlations with serum cortisol at rest 
(Vining et al., 1983; O’Connor and Corrigan, 1987; Lippi et al., 2009; Duplessis et al., 2010) 
and has been suggested as a reliable marker to use in response to exercise stress (O’Connor 
and Corrigan, 1987; Cadore et al., 2008; Crewther et al., 2010). An early study by O’Connor 
and Corrigan (1987) examined the salivary and serum cortisol response to 30 min of cycling 
at 75% V̇O2max. The authors reported a strong positive correlation between salivary and 
serum cortisol at rest (r = 0.89), immediately after exercise (r = 0.90) and 15 min post-
exercise (r = 0.93). 
Circulatory cortisol specifically aims to maintain a state of homeostasis during non-stressful 
and stressful environments by acting on peripheral organs via intracellular receptors 
throughout the body (Bamberger, Schulte and Chrousos, 1996). Actions of cortisol include 
energy metabolism, liver gluconeogenesis, enhances lipolysis, and influences blood pressure 
and electrolyte balances. Cortisol also acts upon physiological systems such as the immune 
system and the cardiovascular system (Kudielka and Kirschbaum, 2005).  
 
2.2.2 Cortisol Responses to Acute Exercise 
Cortisol can be increased following physical exercise (Davies and Few, 1973; Hill et al., 
2008). This increase in cortisol levels in response to exercise is dependent upon the intensity, 
duration, mode of exercise and training status (Meeusen et al., 2013). A general consensus 
within the literature suggests that an increase in exercise intensity causes a proportional 
increase in cortisol concentrations, peaking 15-30 min post-exercise and returning to baseline 
levels within one hour (McKeever, 2002). In order for cortisol concentrations to increase, a 
specific exercise intensity threshold must be attained. Studies have established that the 
exercise must be moderate to high-intensity (>60% V̇O2max) lasting at least 20-30 min in 
duration to induce increases in circulating cortisol levels (Luger et al., 1987; Brownlee, 
Moore and Hackney, 2005; Hill et al., 2008). Hill et al. (2008) examined the plasma cortisol 
response to 30 min of exercise at intensities of 40, 60 and 80% of individuals V̇O2max in 12 
active moderately trained males. They observed a significant increase from pre-exercise 
values of 40% post-exercise at 60% V̇O2max and an 83% increase post-exercise at 80% 
V̇O2max. Exercise-induced cortisol increases have also been shown to occur following short-
duration, high-intensity exercise (~75% V̇O2max) in healthy males (Meeusen et al., 2004; 
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Hough et al., 2011, 2013). In comparison, exercise of lower intensities (40% V̇O2max) does 
not cause significant increases in cortisol with one study suggesting that circulatory cortisol 
levels is reduced once plasma volume reduction and circadian factors were corrected for (Hill 
et al., 2008). However, it should not be assumed that cortisol responses to exercise will occur 
immediately with increases shown to occur at approximately four minutes (Port, 1991). 
Therefore, it is evident from previous research that the exercise intensity and duration is 
important to elicit significant cortisol responses when designing the exercise protocol.  
The training status of the athlete can also have an influence on the cortisol response to acute 
exercise. Paccotti et al. (2005) investigated plasma and salivary cortisol responses to an acute 
bout of high-intensity isokinetic exercise in endurance trained athletes, power-trained athletes 
(n = 20) and non-competitive athletes (n = 11). They reported a 107% higher salivary 
cortisol response in the endurance and power-trained athletes compared to the non-
competitive athletes immediately after exercise (22.1 ± 16.4 vs 10.7 ± 5.9 nmol·L
-1
) as well 
as 90 min (29.2 ± 19.8 vs 17.1 ± 20 nmol·L
-1
) and 120 min after exercise (22.2 ± 16.2 vs 11.7 
± 12.1 nmol·L
-1
). This difference between endurance, power-trained and non-competitive 
athletes is supported by the moderate to large ES observed in this study which highlights the 
extent of varying training status can have on the cortisol response. A similar finding was also 
observed between competitive athletes (n = 20) and sedentary individuals (n = 10) after 
performing isokinetic exercise (Minetto et al., 2007). It was reported that exercise-induced 
salivary cortisol response was 96% higher in competitive athletes (22.1 ± 16.4 nmol·L
-1
) 
compared to sedentary individuals (11.3 ± 5.9 nmol·L
-1
). A large ES was observed between 
competitive and non-competitive athletes. A summary of the cortisol responses to acute 
exercise is presented in Table 1. 
 
2.2.3 Testosterone and the Hypothalamic-Pituitary-Gonadal axis 
The HPG axis is also a major component of the endocrine system. Neurons located within the 
hypothalamus produce and secrete gonadotrophin-releasing hormone (GnRH) in response to 
stress and therefore activate the HPG axis (Kim, 2007). GnRH is then transported to the 
anterior pituitary gland via the hypothalamic hypophyseal portal vein where GnRH stimulates 
the production of luteinizing hormone (LH) from the gonadotrophs (Kim, 2007). 
Gonadotrophs are a sub-type of basophil cells found in the medial section of anterior pituitary 
gland which secrete hormones (specifically LH) and act upon the reproductive organs 
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(Hinson, Raven and Chew, 2010). The anterior pituitary gland releases LH into circulation 
and is taken up by the gonads stimulating the release of testosterone. Explicitly within the 
gonads, LH is responsible for the testosterone production in the Leydig cells of males 
(Vingren et al., 2012). LH is processed further as it binds to G-protein-coupled membrane 
receptor, activating cyclic adenosine monophosphate-dependent protein kinases (protein 
kinase A) which is responsible for the stimulating the rate-limiting step in the synthesis of 
testosterone (Miller, 1988). Moreover, testosterone cannot be stored in the cells that produce 
it due to being anabolic in nature and therefore it is released instantly from the cells following 
production (Vingren et al., 2012). Similar to cortisol, testosterone is regulated by a negative 
feedback loop and the central nervous system (CNS). The negative feedback loop acts by 
inhibiting GnRH release via hypothalamus and signalling the gonads to inhibit LH response 
to GnRH (Hinson, Raven and Chew, 2010). 
Once testosterone has been released into circulation, the majority of it is bound to binding 
proteins that are hydrophilic due its inability to dissolve into the blood easily (Vingren et al., 
2012). Within plasma, testosterone specifically binds to sex hormone-binding globulin 
(SHBG) (44-60%) and non-specifically albumin (38-54%) which represents the total fraction 
of testosterone (Cumming and Wali, 1985; Hayes, Bickerstaff and Baker, 2010). The 
remainder (0.2-2%) is the free fraction of testosterone which is unbound within plasma, 
however, it is the most biologically active fraction of testosterone (Kraemer et al., 1998). 
Albumin-bound testosterone is also biologically active which means that both are readily 
available for tissue uptake compared to testosterone bound to SHBG (Pardridge, 1986; 
Hayes, Bickerstaff and Baker, 2010). Therefore, free and albumin-bound testosterone has 
been suggested to be a better marker of total testosterone in plasma (Hayes, Bickerstaff and 
Baker, 2010). Testosterone is not just limited to plasma and can be diffused into salivary 
glands through intracellular mechanisms with research suggesting that the majority of 
testosterone which is diffused into salivary glands is limited to the free fraction of 
testosterone (Rilling et al., 1996).  
Several studies have shown a very strong, positive correlation (r = 0.70-0.97) between blood 
and saliva in males at rest (Wang et al., 1981; Sannikka et al., 1983; Vittek et al., 1985; 
Shirtcliff, Granger and Likos, 2002) and therefore salivary testosterone levels can be used as 
an index of free serum testosterone. Vittek et al. (1985) examined the relationship between 
salivary and serum free and total testosterone concentrations in 45 healthy individuals and 
found a significant positive relationship between salivary and serum free testosterone 
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concentrations (r = 0.97). The exercise-induced salivary testosterone responses have been 
shown to have a positive correlation with the exercise-induced serum testosterone levels 
(Crewther et al., 2010).  
Testosterone is an androgen, steroid hormone produced from cholesterol (Vingren et al., 
2012). It is responsible for exerting anabolic actions upon muscle tissue, specifically to 
increase protein synthesis and decrease protein degradation to enhance muscle growth 
(Loebel and Kraemer, 1998). Testosterone also influences the development of male 
reproductive system, cardiovascular system and immune system (Vingren et al., 2012). 
 
2.2.4 Testosterone Responses to Acute Exercise  
Testosterone responses to acute exercise are of similar nature to cortisol in which testosterone 
increases linearly to the exercise intensity (Wilkerson, Horvath and Gutin, 1980). However, 
peak concentrations of total and free testosterone occur at the end of the exercise bout and are 
expected to return to, or below, baseline within 30 min of exercise (Kvorning et al., 2007). It 
has been shown that circulatory levels of total and free testosterone increase instantly 
following resistance and endurance exercise (Cadore et al., 2008; McCaulley et al., 2009; 
Hough et al., 2011). Hough et al. (2011) examined plasma and salivary testosterone 
responses to three endurance-based cycling bouts (continuous cycle to fatigue, 30 min 
cycling alternating every 1 min at 60% Ẇmax and 90% Ẇmax [60/90] and 30 min 55/80 cycling 
bout) and resistance exercise (squatting 8 sets of 10 reps at 10 rep max) in ten healthy males. 
Hough and colleagues reported plasma and salivary testosterone responses to significantly 
increase by ~60-120% (cortisol) and ~35-82% (testosterone) following all exercise trials with 
peak concentrations occurring at 0 and ~10 min post-exercise. Furthermore, plasma and 
salivary testosterone levels were shown to return to pre-exercise levels at 30 min post-
exercise in the cycle to fatigue and 60/90 trial and 40 min post-exercise in the 50/80 trial. 
Additionally, similar findings have been reported in a study by Collomp et al. (2008) who 
found that plasma-free testosterone responses increased by 66% following  a 30 min cycle at 
75% V̇O2max in eight recreational male athletes.  A summary of the testosterone responses to 
acute exercise are presented in Table 1.
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Table 1 Overview of the salivary cortisol and testosterone responses to acute exercise. 
Author Participants Exercise Exercise duration Cortisol response Testosterone response 
Collomp et al. (2008) 8 recreational male 
athletes 
Cycle at 75% V̇O2max 30 min N/A 66% increase 
Hill et al. (2008) 12 actively moderately 
trained males 
Treadmill running at 40, 60 and 
80% V̇O2max 
30 min 40% increase at 60% 
V̇O2max and 86% increase at 
80% V̇O2max 
N/A 
Hough et al. (2011) 10 healthy males Cycling at ~75% Ẇmax 30 min 120% increase 35% increase 
McCaulley et al. (2009) 10 males Resistance exercise – 4 sets of 10 
squats at 75% 1 rep max 
~15 min 12% increase 32% increase 
Meeusen et al. (2004) 7 well-trained male 
cyclists 
Graded exercise incremental test 
until exhaustion 
~23 min 32% increase N/A 
Minetto et al. (2007) 20 competitive athletes 
and 10 sedentary 
individuals 
Isokinetic exercise (total of 160 
isokinetic contractions) 
15 min 96% increase N/A 
Paccotti et al. (2005) 20 competitive 
endurance and power-
trained male athletes 
High-intensity isokinetic exercise 
(total of 160 maximal 
contractions of knee flexor and 
extensor muscle groups) 
15 min 77% increase N/A 
Leal et al. (2017) 10 active healthy active 
males 
High-intensity running test (1 
min at 11 RPE and 4 min 15 
RPE) 
30 min 64% increase  42% increase 
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2.2.5 Cortisol and Testosterone Responses to Intensified Training Periods 
Studies examining the resting and exercise-induced cortisol and testosterone responses to 
periods of intensified training have shown contrasting findings with increases, decreases and 
no changes being reported. A longitudinal study by Filaire et al. (2004) investigated the 
resting hormonal responses of 12 national cyclists where the training load was progressively 
increased over a period of 8 months. They found that no significant salivary cortisol and 
testosterone changes occurred. The resting hormonal measurements to shorter periods of 
intensified training have also been shown to be equivocal. Ishigaki et al. (2005) examined the 
relationship between resting plasma cortisol and testosterone levels in 13 collegiate male 
distance runners before and after an eight day training camp. The authors reported a 
significant increase (42%) in plasma cortisol concentrations (pre-training: 326.2 ± 55.2; post-
training: 463.1 ± 110.1 nmol·L
-1
) and a significant decrease (35%) in plasma testosterone 
concentrations (pre-training: 14.2 ± 4.4; post-training: 9.2 ± 3.4 pmol·L
-1
).  Slivka et al. 
(2010) reported that salivary cortisol and testosterone did not change in eight trained cyclists 
over a period of 21 days of intensified training where volume and intensity increased by 
418% of normal training period. In contrast, examining the exercise-induced hormone 
responses to periods of intensified training have produced more consistent findings to identify 
overreached athletes or athletes who may be at risk of developing the OTS (Meeusen et al., 
2004, 2010; Hough et al., 2013; Hough, Robertson and Gleeson, 2015).  
As detailed previously, Meeusen et al. (2004) found blunted exercise-induced plasma cortisol 
responses following 10 day training camp between overreached and normally-trained 
individuals. Furthermore, Hough et al. (2013) observed a blunted salivary exercise-induced 
cortisol and testosterone response following an 11 day intensified training period. Blunted 
salivary exercise-induced testosterone responses have also been shown to occur in elite male 
triathletes (Hough, Robertson and Gleeson, 2015). Using the same 55/80 cycling protocol 
from previous studies, Hough and colleagues reported an exercise-induced salivary 
testosterone decrease from 114% to 85% following a 10 day training camp (where volume 
and intensity of the exercise were elevated). However, salivary cortisol responses were 
unaltered from pre- to post-training. This could suggest that testosterone may be a better 
marker of overreaching, specifically in elite athletes. A summary of the salivary cortisol and 
testosterone responses to intensified training periods are presented in Table 2. 
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Table 2 Overview of the salivary cortisol and testosterone responses to intensified training periods. 
 
 
Author Participants  Training duration Sample type (resting or exercise) Cortisol response Testosterone response 
Filaire et al. (2004) 12 elite national male cyclists 8 months Rest No change No change 
Flynn et al. (1994) 8 male cross-country runners 6 weeks Rest No change  No change 
Hooper et al. (1995) 14 male and female swimmers  6 months Rest No change No change 
Hough et al. (2013) 12 recreationally active males 11 days Exercise 72% decrease 37% decrease 
Hough et al. (2015) 7 elite male triathletes 10 days 
 
Exercise No change 25% decrease  
Ishigaki et al. (2005) 13 male collegiate runners 8 days Rest 42% increase   35% decrease  
 
Meeusen et al. (2004) 7 well-trained male cyclists 10 days Exercise 113% decrease N/A 
Slivka et al. (2010) 8 male cyclists 21 days Exercise No change No change 
Urhausen et al. (1998) 17 male endurance athletes 19 months Rest No change No change 
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2.3 Markers of Overreaching – Immune Responses 
Given that overreaching is a result of intensified training combined with inadequate recovery, 
this could increase the duration of the “open-window” leading to immunosuppression 
(Halson and Jeukendrup, 2004). It has been suggested that endurance athletes during periods 
overreaching/overtraining and competition experience illnesses more frequently, especially 
URS (Nieman, 2003). It has been suggested that URS are viral in nature, however, the key 
immunological mechanisms which underpin the increased occurrence of URS in athletes 
compared with non-athletes still remains unclear within the literature (Gleeson and Bishop, 
2013). Although the exact mechanisms cannot be explained, a relationship between exercise 
intensity/volume and susceptibility to the URS does exist and may be modelled in the form of 
a J-shaped curve (Nieman, 1994b, 1994a). The J-shaped curve model suggests that exercise 
intensity/volume of moderate levels reduces the risk of URS to below average compared to 
individuals who perform sedentary levels of exercise. However, individuals who perform 
periods of high-intensity exercise or periods of intensified training increase the risk of URS to 
levels above average.  
The importance of the immune system for defence against pathogenic (disease-causing) 
micro-organisms including bacteria, protozoa, viruses and fungi is essential in ensuring that 
the homeostasis of the human body is maintained (Gleeson, Bishop and Walsh, 2013). 
Although, hormonal alterations could be indicative of overreaching and the OTS, the 
literature also suggests that immunological responses could also help identify and prevent 
these states from occurring (Halson and Jeukendrup, 2004; Meeusen et al., 2013; Kreher, 
2016). Growing interest into the immune system as a potential indicator of overreaching is 
due to its association with the endocrine system. Given that stress (exercise) activates the 
HPA axis, which in turn releases cortisol, it has been suggested to act upon the immune 
system by either being immunomodulatory or immunosuppressive (Dhabhar, 2009). 
Naturally produced cortisol has been shown to be immunomodulatory whereas high levels of 
cortisol has been shown to be immunosuppressive (Dhabhar, 2009). Walsh et al. (2011) 
suggests that chronic exercise/periods of intensified training induce elevations in cortisol 
production which could attribute to the down-regulation of IgA synthesis and polymeric 
immunoglobulin receptor (pIgR) expression resulting in the IgA response to be suppressed. 
IgA is one of the primary antibodies within mucosal immunity and is produced via mature B 
cells located in the blood and acts as a defence mechanism against pathogens in the oral and 
nasal cavities (Gleeson, 2000; Gleeson and Pyne, 2000). One study has examined the 
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influence of a single synthetic glucocorticoid dexamethasone injection on salivary IgA 
concentrations and secretions and they found that salivary IgA decreased 24 h after the 
injection (Wira, Sandoe and Steele, 1990). Therefore, during periods of intensified training, 
cortisol could supress the synthesis of IgA by B cells in the submucosa (Saxon et al., 1978). 
However, the mechanisms which underpin the exercise-induced SIgA responses still remains 
unclear and more studies need to be undertaken to clarify them (Walsh et al., 2011).  
Specifically within the mucosal immune system, SIgA has been suggested as marker of 
overreaching and the OTS (MacKinnon, 2000). Tomasi et al. (1982) were the first to examine 
the mucosal immune responses to exercise, suggesting that individuals were more susceptible 
to viral and bacterial infections following intense exercise due to deficiency on the mucosal 
surface. This speculation was after observing a 20% decrease in SIgA concentrations in elite 
cross-country skiers compared with recreational athletes following two to three hours of 
competition. Since then a number of studies have been published investigating the mucosal 
immune responses to acute exercise and periods of intensified training. 
 
2.3.1 Immunoglobulin A 
The mucosal immune system is an important component of the acquired immune system as it 
provides the first line of defence against potential pathogens invading the oral and nasal 
cavities (Gleeson and Pyne, 2000). The primary antibody of the mucosal immune system is 
IgA which is a glycoprotein produced by mature B cells in the blood and secreted into bodily 
fluids such as saliva, tears, nasopharyngeal, bronchial, intestinal and urogenital secretions 
(Gleeson, 2000). As the primary antibody, IgA has a number of functions to fulfil across the 
mucosal surfaces such as the linings of the respiratory, gastrointestinal and genitourinary 
tracts (Woof and Ken, 2006).  
IgA consists of two isotypes known as IgA1 and IgA2 (Gleeson and Pyne, 2000). Each 
isotype distributes itself depending on the mucosal site, for example, the majority of IgA1 is 
in the salivary glands (60-80%) and the nasal-associated lymphoid tissue (90%) (Gleeson and 
Pyne, 2000). Whereas, the majority of IgA2 is in the distal gastrointestinal tract (60%) 
(Gleeson and Pyne, 2000). Initially, IgA in its monomeric form is secreted by the B cells 
(plasma cells) and forms dimeric IgA when two IgA monomers are joined together by a small 
polypeptide structure called the J-chain (Tsujita and Morimoto, 1999). Dimeric IgA 
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molecules diffuse through the basement membranes to bind to the pIgR located on the 
basolateral surfaces of the epithelial cell (Bishop and Gleeson, 2009). The binding process to 
pIgA enables transcytosis of IgA across the mucosal epithelium where pIgR is proteolytically 
cleaved at the apical surface which leaves the secretory component bound to the dimeric IgA 
molecule and therefore forming secretory IgA (Lamm, 1998; Bishop and Gleeson, 2009). The 
secretory component of IgA is essential to the stability of IgA and prevents degradation by 
bacterial and digestive enzymes in secretory fluids such as saliva (Johansen, Braathen and 
Brandtzaeg, 2001). This process fulfils three potential mechanisms in which SIgA protects 
against microbial pathogens: through prevention of pathogen adherence and penetration of 
the mucosal epithelium, by neutralising viruses within the epithelial cells during transcytosis 
and by removal of locally formed immune complexes across mucosal epithelial cells to the 
luminal surface (Lamm, 1998).  
 
2.3.2 Salivary Secretory IgA Responses to Acute Exercise 
The association between acute bouts of exercise and the SIgA response is largely dependent 
upon the intensity, duration and the mode of exercise (Walsh et al., 2011). High-intensity 
exercise has been shown to decrease SIgA concentrations in many studies with levels 
returning to baseline within 1 h of exercise completion (Tomasi et al., 1982; MacKinnon and 
Jenkins, 1993; Nieman et al., 2002; Walsh et al., 2002). However, some studies have 
reported increases (Dorrington, Gleeson and Callister, 2003; Sari-Sarraf et al., 2007) and no 
changes occurring at all (Mackinnon and Hooper, 1994). Moderate to low-intensity (<60% 
V̇O2max) aerobic exercise lasting less than one hour have minimal impact on SIgA 
concentrations (Bishop and Gleeson, 2009) and SIgA concentrations are generally unchanged 
following resistance exercise (Koch, 2010) and moderate to high-intensity 
intermittent/interval exercise (Bishop et al 1999, Davison 2011). Mackinnon et al. (1989) 
examined salivary IgA responses to 2 h of cycling at 70-75% V̇O2max in 8 male cyclists. They 
found that salivary IgA concentrations decreased post-exercise by 63% and remained at this 
level for one hour post-exercise with levels returning to baseline within 24 h of exercise. 
Further studies have been conducted on endurance exercise and have shown salivary IgA 
secretion rate to significantly decrease by 34% following competitive marathon running 
(Nieman et al., 2002) and ultramarathon running (Palmer et al., 2003). To the contrary, 
Walsh et al. (2002) has shown a 17% increase in SIgA concentrations in well-trained cyclists 
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following 2 h cycling at 70% V̇O2max. Comparable findings have also been found by Laing et 
al. (2005) who reported a 21% increase in salivary IgA concentrations (pre-exercise: 91 ± 12; 
post-exercise: 110 ± 13 mg·L
-1
) following 2 h cycling at 65% V̇O2max. Overall, the majority 
of the literature suggests that long-duration exercise has a negative impact on SIgA 
responses. However, limited amount of research has been conducted on the impact of SIgA 
responses to short-duration, high-intensity exercise (Allgrove et al., 2008). 
Short-duration (~30 min), high-intensity exercise has been shown to increase SIgA 
concentrations and secretion rates (Blannin et al., 1998; Allgrove et al., 2008). An early study 
examined the effect of cycling to exhaustion at different intensities (55% and 80% V̇O2max) 
on salivary IgA concentrations and secretion rate (Blannin et al., 1998). They found that 
salivary IgA concentrations (pre-exercise: 88 ± 11; post-exercise: 265 ± 34 mg·L
-1
)
 
and 
secretion rate (pre-exercise: 18.9 ± 3.5; post-exercise: 29.9 ± 4.6 µg·min
-1
)
 
significantly 
increased by 201% and 58% following an 80% V̇O2max cycle to exhaustion test (~37 min). 
Moreover, Allgrove and colleagues investigated the effects of different exercise intensities 
(50% V̇O2max, 75% V̇O2max and incremental test to exhaustion) in 10 healthy active males 
and they reported a significant increase in salivary IgA concentrations (56%) and secretion 
rates (50%) post-exercise during incremental test to exhaustion only. This study highlights 
that short-duration, high-intensity exercise induces an increase in the SIgA response. 
However, it is clear that SIgA responses to acute exercise still remains inconsistent due to the 
difference in protocols, collection methods used (stimulated vs unstimulated) and how SIgA 
is expressed (i.e. absolute concentration or as a secretion rate) (Walsh et al., 2011). A 
summary of the SIgA responses to acute exercise are presented in Table 3. 
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Table 3 Overview of the SIgA responses to acute exercise. 
Author Participants Exercise Exercise duration IgA expression IgA response 
Allgrove et al. (2008) 10 healthy active males Incremental cycle test to 
exhaustion 
~22 min Absolute concentration 
Secretion rate 
56% increase 
50% increase 
Blannin et al. (1998) 18 healthy active males Cycle to exhaustion at 80% 
V̇O2max 
~37 min Absolute concentration 
Secretion rate 
201% increase 
58% increase 
Laing et al. (2005) 13 healthy males Cycle at 65% V̇O2max 2 h Absolute concentration 
Secretion rate 
15% increase 
35% decrease 
Mackinnon and Hooper 
(1994) 
18 recreational-
competitive male and 
female endurance athletes 
Treadmill run at 55% and 75% 
V̇O2max 
40-90 min 
 
Secretion rate No change  
Mackinnon and Jenkins 
(1993) 
12 healthy active males Five 60 s bouts of supramaximal 
interval exercise at 0.075 g·kg
-1 
body mass on the cycle 
ergometer 
5 min Absolute concentration 
Flow rate 
19% increase 
50-65% decrease 
Mackinnon et al. (1989) 8 male cyclists Cycle at 70-75% V̇O2max 2 h Absolute concentration 63% decrease 
Nieman et al. (2002) 98 male and female 
runners 
Competitive marathon race ~4.5 h Absolute concentration 
Secretion rate 
19% decrease  
34% decrease 
Palmer et al. (2003) 28 ultramarathon male and 
female runners 
Ultramarathon 80 km race 5-12 h Absolute concentration 
Secretion rate 
27% decrease 
45% decrease 
Sari-Sarraf et al. (2007) 10 healthy active males Soccer-specific intermittent 
exercise 
90 min Absolute concentration 
Secretion rate  
186% increase 
128% increase 
Tomasi et al. (1982) Elite and recreational Cross-country skiing race 2-3 h Absolute concentration 20% decrease 
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cross country skiers  
Walsh et al. (2002) 15 trained male cyclists Cycle at 70% V̇O2max 2 h Absolute concentration 
Secretion rate 
Flow rate 
17% increase 
20% decrease 
31% decrease 
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2.3.3 Salivary Secretory IgA Responses to Intensified Training Periods 
To date, an abundant amount of research has been conducted on SIgA responses to long-term 
training (>1 month) with many studies showing a negative relationship between SIgA 
responses (decrease) and URS (increased incidence). Many of these studies have measured 
resting SIgA responses before, during and after a competitive season. In an early and much 
cited study by Gleeson et al. (1995, 1999), a 10% decrease in salivary IgA concentrations 
were observed after individual training sessions in elite swimmers whereas salivary IgA 
concentrations increased by 11% in controls. Furthermore, salivary IgA concentrations were 
found to decrease over a 7 month period in both pre- and post-exercise samples. The findings 
from this study suggest daily intense exercise sessions over a long period of time supress the 
mucosal immune function. A number of long-term studies have also found similar results that 
have been examined in elite swimmers (Tharp and Barnes, 1990), American college football 
players (Fahlman and Engels, 2005) and elite yacht players (Neville, Gleeson and Folland, 
2008).  
Contrary to these findings, Mackinnon and Hooper (1994) reported no significant changes in 
resting salivary IgA over a 6 month competitive season in 14 elite swimmers. Although, they 
did observe that salivary IgA concentrations were consistently lower by 18-32% in stale 
athletes and possibly predisposed to OTS (defined as a failure to improve performance from 
early season and persistent fatigue) compared with well-trained swimmers (n = 3). Therefore, 
suggesting that mucosal immunity is suppressed further in overreached and OTS athletes. In a 
more recent study, symptoms of URS were monitored during a 4 month period of winter 
training to assess the function of the immune system in 80 endurance athletes (ranging from 
recreational to Olympic level) (Gleeson et al., 2012). Gleeson and colleagues found that 
athletes with symptoms of URS did not have significantly different resting salivary IgA 
concentrations compared with athletes with no URS (145 ± 79 vs 155 ± 95 mg·L
-1
). Although 
they did find that resting salivary IgA secretion rate (49.3 ± 35.8 vs 80.3 ± 52.5 µg·min
-1
) and 
flow rate (0.35 ± 0.19 vs 0.53 ± 0.24 mL·min
-1
) were significantly lower in athletes with URS 
compared to those with no symptoms. Furthermore, one study showed no significant changes 
in the resting salivary IgA samples in 41 elite swimmers over a 5 month period leading up to 
the 1998 Olympic Games (Pyne et al., 2001). 
Short-term training studies have also shown comparable results to long-term training studies. 
Studies designed to intensify the training load to induce a state of overreaching have also 
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shown to decrease salivary IgA responses from pre- to post-training (Mackinnon, 1996; 
Robson et al., 1999; Gleeson, Ginn and Francis, 2000; Gleeson et al., 2002; Libicz et al., 
2006). A 67% decreased in resting concentrations of salivary IgA immediately before the 
onset of URS symptoms were found during a 30 day period of intensified training (load) in a 
group of elite male swimmers (Gleeson et al., 2002). A similar finding has been reported in 
one male elite kayaker in which salivary IgA response decreased by 69% following a 14 day 
intensified training period (Gleeson, Ginn and Francis, 2000). A criticism of this study would 
be that only one participant was used. A study by Robson et al. (1999) found that resting 
salivary IgA concentrations fell by ~10% in endurance trained male runners following 2-3 
weeks of intensified training. Furthermore, suppressed levels of salivary IgA in terms of 
concentration, secretion rate and flow rate were also shown to occur in elite male triathletes 
during the 6 day French Iron Man Tour (Libicz et al., 2006). Over the course of the 6 days, 
salivary IgA secretion rate fell by 52%.  
Several studies have also examined the mucosal responses to periods of military training 
which gives a further understanding of the responses expected to happen during periods of 
intensified training which can mean many of these individuals are in a 
overreached/overtrained state (Carins and Booth, 2002; Gomez-Merino et al., 2005; Tiollier 
et al., 2005). A study using 29 military recruits used SIgA as marker to assess mucosal 
immunity during a 19 day Royal Air Force survival course (Carins and Booth, 2002). They 
found a negative relationship between SIgA and the occurrence of URS. Moreover, Tiollier et 
al. (2005) examined salivary IgA responses to 3 weeks of military training followed by a 5 
day combat course and reported no changes in salivary IgA concentrations following 3 weeks 
of military training. Although no changes were observed following the 3 weeks of training, 
Tiollier and colleagues found a ~41% decrease after the 5 day combat course. These studies 
highlight how intensified periods of training have a damaging effect on SIgA responses 
which in turn leads to higher incidences of URS. Although military studies provide a useful 
insight, exercise alone may not be the sole contributor to the responses observed as many of 
these studies involve other stressors such as dietary energy deficiencies, sleep deprivation and 
psychological challenges. These stressors could therefore influence the immuno-endocrine 
responses and as a result increasing the exercise-induced alterations (Oliver et al., 2007).  
Much of literature suggests that both long-term and short-term periods of intensified training 
have a profound impact on the mucosal immunity. Many studies have shown resting levels of 
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SIgA concentrations and secretion rates to be suppressed from pre- to post-training which 
may be a predisposition to high URS susceptibility in athletes (Walsh and Oliver, 2016). 
However, there is still a lack of literature surrounding the exercise-induced SIgA responses to 
periods of intensified training. A summary of the SIgA responses to intensified training 
periods are presented in Table 4. 
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Table 4 Overview of the SIgA responses to intensified training periods. 
Author Participants Training duration 
Sample type (resting 
or exercise) 
IgA expression IgA response 
Carins and Booth (2002) 29 Australian Air Force 19 days Rest Absolute concentration 33% decrease 
Fahlman and Engels (2005) 100 male American 
college football players 
12 months Rest Absolute concentration 
Secretion rate 
38% decrease 
30% decrease 
Gleeson et al. (1995) 26 elite swimmers 7 months Exercise Absolute concentration  
 
10% decrease 
Gleeson et al. (2000) 1 elite male kayaker 14 days Exercise Absolute concentration 69% decrease  
Gleeson et al. (2002) 14 elite male swimmers 30 days Rest Absolute concentration 67% decrease 
Gleeson et al. (2012) 80 male and female 
endurance athletes  
4 months Rest Absolute concentration 
Secretion rate 
Flow rate 
No change 
39% decrease 
33% decrease 
Libicz et al. (2006) 8 elite male triathletes 6 days Exercise Absolute concentration Flow 
rate 
Secretion rate 
38% decrease 
56% decrease 
52% decrease 
Mackinnon and Hooper 
(1994) 
14 elite swimmers 6 months Rest  Absolute concentration 18-32% decrease (stale 
athletes) 
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Neville et al. (2008) 38 elite yacht racing 
athletes 
50 weeks Rest Absolute concentration 28% decrease (3 weeks 
prior to URS episodes) 
Pyne et al. (2001) 21 elite male swimmers 5 months Rest Absolute concentration No change 
Robson et al. (1999) 8 endurance trained male 
runners 
2-3 weeks Rest Absolute concentration 10% decrease 
Tharpe and Barnes (1990) 21 elite male swimmers 3 months Exercise Absolute concentration 53% decrease 
Tiollier et al. (2005) 21 male military cadets 4 weeks Rest Absolute concentration No change (3 weeks 
training) 
41% decrease (5 day 
combat course) 
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2.4 Circadian Rhythm 
It well established within the literature that cortisol and testosterone are hormones regulated 
via a circadian rhythm and is one of the most distinctive within human physiology (Hill et al., 
2008). It is understood that circadian rhythms are biological variations which are repetitive in 
nature and occur approximately over a 24 h period (Reilly and Waterhouse, 2009). Research 
has suggested that under natural conditions, circadian rhythms are self-sustaining endogenous 
biological timekeepers due to their ability to be synchronised with the external world 
(Mrosovsky et al., 1989; Pittendrigh, 1993). As a result, individuals can anticipate and 
prepare for challenges which arise during the day and night (Hastings, O’Neill and 
Maywood, 2007). The circadian rhythm of cortisol and testosterone is regulated by the main 
circadian oscillator known as the suprachiasmatic nucleus (SCN) (also referred to as the 
circadian pacemaker or “biologic clock”) which is located in the anterior hypothalamus 
(Chan and Debono, 2010).  
Healthy individuals experience very low levels of cortisol at midnight that increase overnight 
with levels peaking in the morning 30 min after awakening (Hayes, Bickerstaff and Baker, 
2010). Thereafter, a slow decline in cortisol levels occur throughout the day (Debono et al., 
2009). This steady rise in cortisol overnight is believed to be the body anticipating stresses 
associated with wakefulness and increased activity (Hastings, O’Neill and Maywood, 2007). 
This phenomenon is known as the cortisol awakening response (CAR) (Fries, Dettenborn and 
Kirschbaum, 2009). Factors such as night-time work and daytime sleep have been shown to 
change cortisol’s 24 h cycle by altering sleep-wake rhythm (Czeisler et al., 1990). Normal 
salivary cortisol concentrations range from ~4-15 n·mol
-1 
(Laudat et al., 1988).  
The same circadian rhythmicity also occurs with testosterone (Hayes, Bickerstaff and Baker, 
2010). Levels of testosterone begin to rise at night, peak early morning (between 06:00 and 
08:00 h) and then fall throughout the day (Constantini and Hackney, 2013). Studies have 
shown testosterone concentrations to decline by 42% from 06:00 h (awakening) to 23:00 h 
(Krieger et al., 1971). Normal salivary testosterone concentrations range from ~400-700 
pmol·L
-1
 (Kiess et al., 1995; Kraemer et al., 2001).  
A circadian rhythm has also been reported in SIgA. In contrast to cortisol and testosterone, 
SIgA has been shown to display a different circadian pattern with levels peaking immediately 
upon awakening and then steadily falling throughout the day (Dimitriou, Sharp and Doherty, 
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2002; Shirakawa, Mitome and Oguchi, 2004). Although circadian patterns are different, SIgA 
levels are generally higher in the morning compared to the afternoon. Normal SIgA 
concentrations are ~100 mg·L
-1
 (Jafarzadeh et al., 2010).  
 
2.5 Markers of Overreaching – Performance Testing 
A hallmark feature of overreaching and OTS is the decrease in sport-specific performance 
due to inability to sustain the exercise intensity during increases in training load (Urhausen, 
Gabriel and Kindermann, 1995; Meeusen et al., 2004). In normal circumstances, athletes in a 
healthy state are able to complete the training programme prescribed to them. However, in 
cases where athletes are diagnosed with OTS, they are capable of starting the training 
programme or a race at normal pace but are incapable of completing the training load given 
to them or race as usual (Meeusen et al., 2013). Therefore, it has been suggested that an 
exercise performance test is considered to be essential for the diagnosis of OTS (Halson and 
Jeukendrup, 2004).  
In order to detect changes in performance in overreached and OTS athletes, the type of 
performance test and the intensity/duration need to be carefully considered as the magnitude 
of performance decline may vary (Halson and Jeukendrup, 2004). Therefore, a general 
consensus on which test is the most suitable still remains inconclusive within the literature. A 
number of performance tests exist, and these include time-to-fatigue, incremental and time 
trial (TT) tests. The importance of performance testing has been highlighted in one study 
investigating athletes with persistent fatigue (Reid et al., 2004). They found that in 41 
competitive athletes, 93% of them reported decreases in performance.  
Time-to-fatigue tests have been shown to highlight larger reductions in exercise capacity in 
overreached and OTS athletes or in response to intensified training periods (Fry et al., 1994; 
Meeusen et al., 2004). An early study examined the effects of a 10 day intensified training 
period (included two daily intensive training sessions) on running performance in five well-
trained males (Fry et al., 1994). They found that time-to-fatigue (18 km·h
-1
 and 1% gradient 
on a treadmill) was 29% slower post-training compared to pre-training. Furthermore, 
Urhausen et al. (1998) reported a 27% decrease in time-to-fatigue in overtrained athletes 
(22.7 ± 2.3 min) compared to athletes in a normal trained state (16.6 ± 1.3 min). Although 
larger reductions in performance are reported compared to other methods of testing, they are 
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not an accurate performance indicator as do not sufficiently reflect the true demands of 
athletic competition (Halson and Jeukendrup, 2004). 
Time trial tests have also shown decreases in performance (Jeukendrup et al., 1992; Halson et 
al., 2002, 2003). The benefits of using TT in studies is that they accurately reflect the sport-
specific task of most sports and allow detection of subtle performance decrements compared 
to time-to-fatigue and incremental tests (Meeusen et al., 2013). Jeukendrup and colleagues 
conducted a study investigating the impact of a 2 week intensified training period on cycling 
performance (outdoor 8.5 km TT) in seven male competitive cyclists. They reported a 6% 
decrease in cycling performance from pre- (13.8 ± 0.2 min) to post-training (14.5 ± 0.3 min). 
The same study also reported 3-4% decrease in maximal aerobic power during a graded 
incremental cycle test. In addition, a study by Halson et al. (2002) found a 10% decrease in 
TT performance (59.4 ± 1.9 vs 65.3 ± 2.6 min) and a 6% decrease in maximal power output 
(338 ± 17 vs 319 ± 17 W) following a 6 week intensified training period. These studies have 
highlighted that despite the variations in the type of performance tests used, a decline in 
exercise performance is evident in overreached individuals. Furthermore, the use of TT in 
overreaching studies enables other variables to be measured such as substrate kinetics, 
hormonal responses and sub-maximal measures (Meeusen et al., 2013).  
 
2.6 Aims and Hypotheses 
The aim of the present study was to determine if there were any hormonal alterations of 
salivary cortisol and testosterone and mucosal immunological responses of SIgA to a 30 min 
high-intensity running bout before and after a 12 day intensified training period.  
The hypotheses for the present study were as follows: 
1. It is hypothesised that a decrease in exercise-induced salivary cortisol and testosterone 
response will be observed following a period of 12 days intensified training. 
2. It is hypothesised that a decrease in exercise-induced SIgA response will be observed 
following a period of 12 days intensified training. 
3. It is hypothesised that a negative relationship between SIgA response and URS incidences 
will occur following a period of 12 days intensified training. 
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4. It is hypothesised that the exercise-induced salivary cortisol, testosterone and SIgA 
responses will return to, or increase above pre-training levels following a 4 day recovery 
period.  
 
2.7 Contributions 
This MSc by Research study was conducted as collaborative effort with Diogo Leal who also 
submitted this as part of his PhD (Leal, 2017). Throughout the study, Diogo and I shared the 
responsibilities in order to complete the study on time. I attended all preliminary testing 
sessions, all main trials and all training days for each participant. During these sessions, I 
collected saliva samples from each participant and I later analysed them in the wet laboratory. 
I also prepared the participants for exercise (i.e. fitting HR monitors), performed the tests (i.e. 
V̇O2max test), monitored each participant to ensure each test protocol were performed 
correctly and I also collected the necessary data needed for the study. Moreover, I was 
involved with participant recruitment and salivary analysis via ELISA method which was 
completed in partnership with Diogo.  
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CHAPTER 3 Methods  
3.1 Power Analyses 
Post-hoc power analyses were conducted with G*Power software version 3.1 (Heinrich 
University, Düsseldorf, Germany). The observed power for salivary cortisol, testosterone and 
SIgA was 0.550, 0.694 and 0.637, respectively.  
 
3.2 Participants 
Eight active, healthy males volunteered to participate in this study (participant physical and 
physiological characteristics are outlined in Table 5). All experimental procedures were 
approved by the University of Bedfordshire’s Research Ethics Committee. An information 
sheet (appendix a) with a full explanation of the study, possible risks and benefits involved 
was given to each participant before testing commenced. On arrival, each participant 
completed an informed consent form (appendix b), physical activity readiness questionnaire 
(PAR-Q) (appendix c) and a health questionnaire (appendix d). 
 
Table 5 Participant physical and physiological characteristics. 
Variable  
Age (years) 21 ± 5 
Height (cm) 178.2 ± 5.2 
Body mass (kg) 72.8 ± 6.6 
HRmax (beats∙min
-1
) 192 ± 9 
vV̇O2max (km∙h
-1
) 16.6 ± 2.2 
Values are mean ± SD. 
 
3.3 Inclusion and Exclusion Criteria 
Prior to the commencement of the study, each participant completed an informed consent 
form, a PAR-Q and a health questionnaire. If participants answered “yes” to the any of the 
PAR-Q questions then they were excluded from the study. Furthermore, participants were 
required to be physically active in which they participated in at least 3 h of exercise per week 
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(Department of Health Physical Activity Health Improvement and Protection, 2011). Night 
shift workers were excluded from the present study as adjustment of their circadian rhythms 
takes at least 4 days (Niu et al., 2015). Any participant carrying an injury was also excluded 
from the present study.  
 
3.4 Experimental Procedures  
All main trials took place at the University of Bedfordshire’s Sport and Exercise Science 
Laboratories. For the main trials, each participant completed the RPEtreadmill bout. This bout 
consisted of a 30 min self-paced continuous run with alternating blocks of 1 min at 11 (fairly 
light) on the 6 – 20 Borg RPE scale and 4 min at 15 (hard) on the Borg RPE scale. See Figure 
3 for main trial schematic. 
 
 
Figure 2 Schematic of overall study. 
 
3.4.1 Familiarisation Trial 
Each participant completed a familiarisation trial three days before the main experimental 
trials began (Figure 2). Each participant was introduced to the equipment and experimental 
procedures. On arrival, each participant completed a recovery-stress questionnaire for athletes 
(RESTQ-76 Sport) (appendix e) and Jackson score URS questionnaire (appendix f). The 
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participant’s height (cm) and body mass (kg) were collected pre-exercise, post-exercise and 
30 min post-exercise. For the familiarisation trial, participants completed the RPEtreadmill bout 
and a 10 km running TT with a one hour seated rest recovery in between. No saliva samples 
were collected for this trial. 
 
3.4.2 Main Trial 
During the main experimental trials, each participant completed the RPEtreadmill bout and a 10 
km running TT on a motorised treadmill (Woodway, PPS55 Med-I, Germany) on three 
separate occasions. The first being 24 h before the maximal exercise test (pre-training), the 
second being 24 h after the 12 day intensified training period (post-training) and the third 
being 4 days after the maximal exercise test (post-recovery) (Figure 2). Each participant came 
to the laboratory at 11:30 to avoid the influence of the circadian rhythm on the hormones. For 
the main experimental trials, participants were asked to consume a standardised breakfast 4 h 
before and remained fasted after consumption until the end of each trial. Each participant 
abstained from alcohol, caffeine and exercise 24 h before the main exercise trials. They were 
also asked to consume 500 mL of water several hours before each trial to help ensure that 
they were in a euhydrated state and normal body electrolyte status when they arrived at the 
laboratory (Sawka et al., 2007). Hydration status was confirmed with a pre-exercise urine 
osmolality test analysis at the beginning of each main experimental trial. 
On arrival, participants completed a RESTQ-76 Sport and Jackson score URS questionnaire. 
The RESTQ-76 Sport was used to identify the physical and mental stress of the athletes 
during the past three days and nights prior to exercise and their current capabilities towards 
recovery (Kellmann and Kallus, 2001). The questionnaire included 48 non-specific and 28 
sport-specific items in which each participant answered using a scale ranging from never (0) 
to always (6). Previous studies have suggested that the RESTQ-76 Sport questionnaire to be a 
useful tool in highlighting changes in training load in overreached and OTS athletes 
(Kellmann and Günther, 2000; Nederhof et al., 2008).  
The Jackson Score URS questionnaire was used to determine the appearance of whether 
participants were suffering from a common cold or flu within three days of the main trials 
(Jackson et al., 1958). Each participant rated the degree of discomfort of their symptoms 
using the Jackson scoring system: “none at all”, “mild”, “moderate” and “severe”. Symptoms 
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included sneezing, headache, malaise, nasal discharge, nasal obstruction, sore throat, cough, 
ear ache, hoarseness, fever, chilliness and joint aches and pains. The use of the Jackson Score 
URS questionnaire in exercise immunology studies has recently been documented in the 
Consensus Statement of Immunonutrition and Exercise as a practical and reliable method for 
reporting URS (Bermon et al., 2017). Previous studies have also shown that this 
questionnaire to be a good indicator of URS (Hanstock et al., 2016). 
Pre-exercise hydration status was determined via a urine sample using an Osmocheck 
Osmolality Refractometer (Osmocheck, Vitech Scientific, West Sussex, UK). Participants 
were deemed euhydrated if urine osmolality was <700 mOsmol·kg
-1 
H2O (Sawka et al., 
2007). If the value was exceeded, participants were required to drink more water until they 
were deemed euhydrated. Two participants failed the osmolality test during the study and 
were asked to consume more water in order to ensure they were euhydrated before 
commencement of the study. Both participants passed the osmolality test the second time. 
Unstimulated saliva samples were collected for three min pre-exercise, post-exercise and 30 
min post-exercise for the RPEtreadmill bout. The participant’s body mass were collected pre-
exercise, post-exercise and 30 min post-exercise to determine sweat rate (Sawka et al., 2007). 
Participants were allowed to consume water ad libitum during the RPEtreadmill bout and 30 min 
post-exercise up until the final 10 min before the saliva collection. Water intake was 
calculated for during exercise (RPEtreadmill) and post-exercise.  
The RPEtreadmill bout began at 12:00 and finished at 12:30. Heart rate [HR; (beats∙min
-1
] 
recorded by telemetry (Polar-FS1, Polar Electro, Kempele, Finland), speed (km·h
-1
) and RPE 
using the Borg Scale was collected in the final 30 s of each 1 min and 4 min stage. Following 
a one hour seated rest recovery, the participant completed a 10 km TT. Time to completion 
(TTC) and average RPE was recorded at the end of the TT. See Figure 3 for main trial study 
schematic. 
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Figure 3 Main trial schematic. 
 
3.5 Graded Exercise Test 
Each participant completed a continuous sub-maximal exercise test on the treadmill 24 h after 
the main exercise trial (Figure 2). This consisted of 4 × 4 min stages (16 min in total). Each 
participant determined their own starting speed between 6.5 km∙h-1 and 12 km∙h-1 and was 
increased by 1 km∙h-1 each stage. Throughout the sub-maximal test, a 1% gradient was used 
as this most accurately reflects the energetic cost of outdoor running (Jones and Doust, 1996).  
Thereafter, the participant had a 20 min recovery before completing a maximal graded 
exercise test to determine the individual’s maximal oxygen consumption (V̇O2max). The test 
began with a gradient of 1% and increased by 1% every 1 min until volitional exhaustion. 
The speed of the V̇O2max test was determined by when the participant reached 150 beats·min
-
1
 or 12 RPE during the sub-maximal exercise test. Throughout the sub-maximal and maximal 
graded exercise test, HR and RPE were recorded at the end of each stage. Expired gas 
(minute ventilation [V̇E], oxygen consumption [V̇O2], and carbon dioxide production 
[V̇CO2]) was analysed by an automated breath by breath gas analyser (Metalyser 3B, Cortex, 
Biophysik, Leipzig, Germany) for the duration of the test. Verbal encouragement was given 
throughout the test.  
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3.6 Saliva Collection and Analysis 
Each participant was allowed to drink water up to 10 min prior to the saliva collection to 
ensure that the saliva sample was not diluted as directed by the cortisol and testosterone 
Enzyme Linked Immunosorbent Assay (ELISA) manufacturers. Throughout the collection 
period, each participant remained seated and was instructed to swallow the contents of their 
mouth before collection began. Each participant then provided an unstimulated saliva sample 
by passive dribble into a 7 mL Bijou tube (Sterilin, Thermo Scientific, Loughborough, UK) 
with eyes open, head tilted forward and making minimal orofacial movement (as completed 
in many saliva collection studies e.g. Hough et al., 2011, 2013). A collection time of a 
minimum of three minutes was allocated in order to allow participants to provide a sufficient 
quantity of saliva. The time was exceeded if the participants had not provided a sufficient 
quantity of saliva within the allocated timeframe. Once the saliva collection process was 
completed, the Bijou tubes were weighed to the nearest milligram to estimate the saliva 
volume. The saliva density was assumed to be 1.0 g·mL
-1
 (Cole and Eastoe, 1988). The saliva 
was then transferred into a 1.5 mL Eppendorf tube (Eppendorf, Hamburg, Germany) and was 
frozen, at –80°C, for later analysis.  
 
3.6.1 Salivary Hormone Analysis 
A commercially available ELISA kits (Salimetrics, PA 16803, USA) were used to determine 
the salivary cortisol and testosterone concentrations according to the manufacturer’s 
instructions. A 96-well microtitre plate were used and pre-coated with monoclonal antibodies 
to cortisol and rabbit antibodies to testosterone. Absorbance values on the microplate reader 
(Infinite® 200 PRO, Tecan GmbH, Switzerland) were measured at 450 ± 10 nm. The mean 
intra-assay coefficients of variation were 4.6% and 4.6% for cortisol and testosterone, 
respectively. The mean inter-assay coefficients of variation were 6.0% and 9.8% for cortisol 
and testosterone, respectively.  
 
3.6.2 Salivary Secretory IgA Analysis 
All samples were transported to the University of Kent to be analysed over a three day period 
for SIgA using an in-house ELISA kits. The methodology of the in-house ELISA kit has been 
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modified from previous research (Leicht, Bishop and Goosey-Tolfrey, 2011) to include a 
capture antibody specific to the secretory component of human IgA. The use of this in-house 
ELISA kit has been utilised in previous exercise studies to measure SIgA (Jones et al., 2015; 
Chidley and Davison, 2017).  
SIgA was expressed as absolute concentration and secretion rate. The SIgA secretion rate was 
calculated using the following equation: 
SIgA secretion rate = absolute SIgA concentration × salivary flow rate (mL·min-1) 
Salivary flow rate = volume of each sample (mL) ÷ collection time of each sample (min) 
 
3.7 Intensified Training Period 
Each participant completed a 12 day intensified training period (Figure 2). The training days 
were completed in the laboratory and on site gym on a motorised treadmill at 1% gradient. 
The final day of training was completed 24 h before the post-training main exercise trial to 
ensure that the participants had sufficiently recovered to complete the post-training main 
exercise trial. To determine the training intensities, velocity at V̇O2max [vV̇O2max] was 
calculated from the sub-maximal exercise test. Each training day consisted of either: (A) 90 
min continuous run (70 min at 55% vV̇O2max and 20 min at 75% vV̇O2max); (B) 5 km TT; (C) 
70 min self-paced continuous run (30 min at 12 RPE, 30 min at 13 RPE and 10 min at 15 
RPE). Each participant completed exercise A on day 1, exercise B on day 2 and exercise C on 
day 3. This three day block of training was repeated four more times (Figure 2). The design 
of this training period was to reduce the monotony of training. Resting HR, average HR, 
HRmax, average RPE, time and distance measurements were collected after each training 
session. Temperature (°C) and relative humidity (%) was also collected.  
 
3.7.1 Training Diaries 
During the 12 day intensified training period, participants were asked to continue their own 
training plan and to record each session. This was to ensure that participants were increasing 
their training load to induce a state of overreaching. Each participant was provided with a 
training log (appendix g), a Borg scale and a HR monitor. Participants were asked to wear the 
39 
 
HR monitor and record the duration, resting HR, average HR, HRmax and average RPE for 
each additional exercise session that was completed outside the laboratory. Each participant 
also provided a 12 day training programme for a normal period of training to act as a control 
measure and this included the same measured variables. 
Training load was determined using Banister training impulse (TRIMP). TRIMP was 
calculated using duration of the training session, resting HR, average HR and HRmax during 
the exercise sessions (see equation below). 
TRIMP =duration (min) × ∆HR ratio × Y 
∆HR ratio= 
HRaverage -HRrest
HRmax -HRrest
  
Where Y = 0.64e
1.92x
, e = 2.712 and x = ∆HR ratio. 
 
3.8 Statistical Analyses 
Statistical analyses were performed using IBM SPSS Statistics Version 22 (SPSS Inc., 
Chicago, IL). Descriptive data was presented as a mean ± standard deviation (SD) and 
percentile differences. Quantile-quantile (Q-Q) plots and Shapiro-Wilk test were used to 
check the normal distribution of data. In the case of non-normally distributed data, 
logarithmic transformations were performed on the data. If normality was violated again 
following logarithmic transformations, a Friedman or multiple Wilcoxon signed ranked non-
parametric test were completed on the original data. In the case of normal distribution, data 
were analysed using a two-way (trial × time) repeated-measures analysis of variance 
(ANOVA). A Student’s paired samples t-tests and Bonferroni post hoc test was used to locate 
the differences in the event of a significant interaction effect. Further analysis was completed 
on participants who completed all three main trials (n = 4) and individual analysis was also 
completed on them. Cohen’s d ES were calculated by dividing the difference between the 
mean of two groups by the pooled SD (Cohen, 1988, 1992). As per Cohen’s guidelines, an 
ES equal to or greater than 0.2, 0.5 and 0.8 represent a small, moderate and large effect. The 
two-tailed alpha level of significance testing was set as p < 0.05. 
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CHAPTER 4 Results 
For the present study, four participants completed 17 visits (all visits except the post-recovery 
main trial) and four participants completed 18 visits in total. Each participant attended a 
familiarisation trial before the main experimental trials began (visit 1). Three main trials (visit 
2, 16 and 18) and two graded exercise tests (visit 3 and 17) were completed by each 
participant. Participants also completed a 12 day intensified training period (visit 4-15). See 
Figure 4. 
 
 
Figure 4 CONSORT diagram. 
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4.1 Tests of Normality 
The assumption of normality was evaluated as a whole group between pre- and post-training 
(n = 8) and determined to be satisfied in training load, V̇O2max, hydration status, 10 km TT 
performance, HR, speed and salivary testosterone. The assumption of normality was violated 
in RPE, salivary cortisol, SIgA concentration, SIgA secretion rate, RESTQ-76 Sport and URS 
questionnaires. Logarithmic transformations were performed on these variables and were re-
evaluated for normality. Salivary cortisol, SIgA concentration and secretion rate were 
deemed to be satisfied and RPE, REST-76 Sport and URS questionnaires were violated 
following re-evaluation. 
The assumption of normality was also evaluated on participants who completed the pre-
training, post-training and post-recovery main trials (n = 4) and determined to be satisfied in 
hydration status, 10 km TT performance, speed and salivary testosterone. The assumption of 
normality was violated in HR, RPE, salivary cortisol, SIgA concentration, SIgA secretion 
rate, RESTQ-76 Sport and URS questionnaires. Logarithmic transformations were performed 
on these variables and were re-evaluated for normality. SIgA concentration was deemed to be 
satisfied and HR, RPE, SIgA secretion rate, RESTQ-76 Sport and URS questionnaires were 
violated following re-evaluation.  
 
4.2 Training Load 
All participants completed the 12 day intensified training period. During the 12 day 
intensified training period, the participants completed 16.7 ± 6.3 h (average of 58.0 ± 9.0 min 
per day) of running compared to the normal 12 day training period in which participants 
completed 8.0 ± 7.8 h (average of 44 ± 31 min per day). The overall TRIMP score 
significantly increased by 118% from the normal 12 day training period (663 ± 616) to the 12 
day intensified training period (1447 ± 471) (p < 0.001). A large ES was observed (1.12). 
 
4.3 Maximum Oxygen Consumption 
Pre- (59 ± 6 mL·kg
-1
·min
-1
) and post-training (59 ± 7 mL·kg
-1
·min
-1
) V̇O2max did not 
significantly differ (p = 0.911). This placed them above 90% of men between 20 and 29 years 
old on the aerobic capacity spectrum according to the American College of Sports Medicine 
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(American College of Sports Medicine, 2018). The participant’s level of training ranged from 
three to seven days per week with levels of performance ranging from recreational to 
competitive.  
 
4.4 Hydration Status 
No significant difference was found between pre- (278 ± 245 mOsmol·kg
-1
) and post-training 
(439 ± 284 mOsmol·kg
-1
) urine osmolality (p > 0.05). No significant main effect (F1, 3 = 
0.492, p = 0.534) was found between pre-training (120 ± 114 mOsmol·kg
-1
), post-training 
(380 ± 314 mOsmol·kg
-1
) and post-recovery (85 ± 30 mOsmol·kg
-1
).  
 
4.5 10 km Time Trial Performance 
No significant difference was found between pre- and post-training 10 km TT performances 
(p = 0.575) (Figure 5). Although no significant differences were found, average 10 km TT 
performance were lower (3%) pre-training (45.2 ± 5.3 min) compared to post-training (46.4 ± 
4.7 min). Two participants were removed from the data analysis due to failing to start the 
post-training 10 km TT. A small ES between pre- and post-training (0.24) was observed.  
No significant main effect (F2, 4 = 3.757, p = 0.121) was found between pre-training (42.3 ± 
5.7 min), post-training (46.9 ± 9 min) and post-recovery (40.8 ± 6.5 min) (Figure 6). The 
calculated ES for 10 km TT performance showed a small ES between pre-training and post-
recovery (0.26), a moderate ES between pre- and post-training (0.76) and a large ES between 
post-training and post-recovery (0.89).  
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Figure 5 Pre- and post-training average 10 km time trial performance (min) (n = 6). Values are mean ± SD. 
 
Figure 6 Pre-training, post-training and post-recovery average 10 km time trial performance (min) (n = 3). 
Values are mean ± SD. 
 
4.6 Physiological Responses 
No significant differences in HR, speed and RPE (p > 0.05) responses to the RPEtreadmill bout 
were found between pre- (HR: 150 ± 4 beats·min
-1
; speed: 10.8 ± 0.5 km·h
-1
; RPE: 13 ± 0)
 
and post-training (HR: 146 ± 3 beats·min
-1
; speed: 11.1 ± 0.4 km·h
-1
; RPE: 13 ± 0) (Table 6).  
No significant differences in HR, speed and RPE (p > 0.05) responses to the the RPEtreadmill 
bout were found between pre-training (HR: 148 ± 19 beats·min
-1
; speed: 10.6 ± 3.8 km·h
-1
; 
RPE: 13 ± 0),
 
post-training (HR: 142 ± 19 beats·min
-1
; speed: 10.6 ± 3.1 km·h
-1
; RPE: 13 ± 
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0) and post-recovery (HR: 147 ± 5 beats·min
-1
; speed: 11.1 ± 2.8 km·h
-1
; RPE: 13 ± 0) (Table 
7).  
 
Table 6 Pre- and post-training average HR (beats·min
-1
), speed (km·h
-1
) and RPE responses to the RPEtreadmill 
bout (n = 8). 
Trial HR (beats·min
-1
) Speed (km·h
-1
) RPE 
Pre-training 150 ± 4 10.8 ± 0.5 13 ± 0 
Post-training 146 ± 3 11.1 ± 0.4 13 ± 0 
Values are mean ± SD. 
 
Table 7 Pre-training, post-training and post-recovery average HR (beats·min
-1
), speed (km·h
-1
) and RPE 
responses to the RPEtreadmill bout (n = 4). 
Trial HR (beats·min
-1
) Speed (km·h
-1
) RPE 
Pre-training 148 ± 19 10.6 ± 3.8 13 ± 0 
Post-training 142 ± 19 10.6 ± 3.1 13 ± 0 
Post-recovery 147 ± 5 11.1 ± 2.8 13 ± 0 
Values are mean ± SD. 
 
4.7 Salivary Hormone Responses 
4.7.1  Salivary Testosterone 
No significant main effect for trial (F1, 7 = 1.222, p = 0.737) and trial × time interaction (F2, 14 
= 0.427, p = 0.661) were found between pre- and post-training. However, a significant main 
effect for time (F2, 14 = 4.833, p = 0.025) was found with a t-test analysis indicating a 
significant increase (36%) from pre- (484.0 ± 194.3 pmol·L
-1
) to post-exercise (658.2 ± 309.6 
pmol·L
-1
) saliva samples pre-training only (p = 0.02) (Figure 7). The exercise-induced 
salivary testosterone response (pre- to post-exercise) decreased by 42% from pre- to post-
training. A small ES between pre- and post-training (0.43) was observed.  
No significant main effect for trial (F2, 6 = 2.224, p = 0.189) and trial × time interaction (F2.105, 
6.316 = 3.43, p = 0.097) were found between pre-training, post-training and post-recovery. A 
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significant main effect of time (F2, 6 = 9.308, p = 0.014) was found with a t-test analysis 
indicating a significant increase (101%) from pre- (424 ± 113 pmol·L
-1
) to post-exercise (851 
± 307 pmol·L
-1
) saliva samples post-recovery only (p = 0.027) (Figure 8). The calculated ES 
for the exercise-induced salivary testosterone response showed a moderate ES between pre- 
and post-training (0.67) and a large ES between pre-training and post-recovery (1.07) and 
post-training and post-recovery (1.24).  
 
Figure 7 Pre- and post-training average salivary testosterone responses (pmol·L
-1
)
 
to the RPEtreadmill bout (n = 8). 
Values are mean ± SD.  
*denotes a significant increase from pre-exercise saliva sample at pre-training (p < 0.05). 
 
Figure 8 Pre-training, post-training and post-recovery average salivary testosterone responses (pmol·L
-1
) to the 
RPEtreadmill bout (n = 4). Values are mean ± SD. 
*denotes a significant increase from pre-exercise saliva sample at post-recovery (p < 0.05). 
200
300
400
500
600
700
800
900
1000
Pre-exercise Post-exercise 30 min post-exercise
S
al
iv
ar
y
 t
es
to
st
er
o
n
e 
(p
m
o
l·
L
-1
) 
Sampling time 
Pre-training
Post-training
0
200
400
600
800
1000
1200
1400
Pre-exercise Post-exercise 30 min post-exercise
S
al
iv
ar
y
 t
es
to
st
er
o
n
e 
(p
m
o
l·
L
-1
) 
Sampling time 
Pre-training
Post-training
Post-recovery
* 
* 
46 
 
4.7.2 Salivary Cortisol  
No significant main effect for trial (F1, 7 = 0.009, p = 0.928) and time (F2, 14 = 2.313, p = 
0.136) were found between pre- and post-training (Figure 9). The exercise-induced salivary 
cortisol response (pre- to post-exercise) increased by 675% from pre- to post-training. A 
small ES between pre- and post-training (0.49) were observed.  
No significant main effect for trial (F2, 6 = 2.487, p = 0.163) and time (F2, 6 = 1.496, p = 
0.297) were found between pre-training, post-training and post-recovery (Figure 10). The 
calculated ES for exercise-induced salivary cortisol response showed a small ES between pre- 
and post-training (0.4) and post-training and post-recovery (0.33) and a large ES between 
pre-training and post-recovery (0.92).  
 
 
Figure 9 Pre- and post-training average salivary cortisol responses (nmol·L
-1
) to the RPEtreadmill bout (n = 8). 
Values are mean ± SD. 
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Figure 10 Pre-training, post-training and post-recovery average salivary cortisol responses (nmol·L
-1
) to the 
RPEtreadmill bout (n = 4). Values are mean ± SD. 
 
4.8 Salivary Secretory IgA Responses 
4.8.1 Salivary Secretory IgA Concentrations 
The resting SIgA concentrations did not significantly differ (p = 0.504) between pre- (132.5 
± 61.8 mg·L
-1
) and post-training (125.7 ± 73.6 mg·L
-1
) (Figure 11). A significant main effect 
for trial (F2, 6 = 5.381, p = 0.046) was found between pre-training, post-training and post-
recovery with a t-test analysis indicating a significant decrease (p =0.028) from pre- (117.7 ± 
17.9 mg·L
-1
) to post-training only (91.3 ± 12.5 mg·L
-1
) (Figure 12).  
No significant main effect for trial (F1, 7 = 0.001, p = 0.978) and time (F1.144, 8.007 = 0.973, p = 
0.366) were found between pre- and post-training (Figure 11). The exercise-induced SIgA 
concentration (pre- to post-exercise) decreased by 4% from pre- to post-training. No ES was 
observed between pre- and post-training.   
No significant main effect for trial (F1, 7 = 0.002, p = 0.969) and time (F2, 14 = 1.262, p = 
0.313) were found between pre-training, post-training and post-recovery (Figure 12). The 
calculated ES for the exercise-induced SIgA concentration showed a small ES between pre- 
and post-training (0.43), a moderate ES between pre-training and post-recovery (0.74) and a 
large ES between post-training and post-recovery (1.23). 
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Figure 11 Pre- and post-training average SIgA concentrations (mg·L
-1
) to the RPEtreadmill bout (n = 8). Values 
are mean ± SD. 
 
 
Figure 12 Pre-training, post-training and post-recovery average SIgA concentrations (mg·L
-1
) to the RPEtreadmill 
bout (n = 4). Values are mean ± SD. 
*denotes a significant decrease for pre-exercise saliva sample from pre- to post-training (p < 0.05). 
 
4.8.2 Salivary Secretory IgA Secretion Rate 
The resting SIgA secretion rate did not significantly differ (p = 0.721) from pre- (39 ± 30 
µg·min
-1
) to post-training (43 ± 18 µg·min
-1
) (Figure 13). No significant main effect for trial 
(F2, 6 = 0.175, p = 0.843) was found between pre-training (46.6 ± 28.4 µg·min
-1
), post-training 
(40.0 ± 13.1 µg·min
-1
) and post-recovery (45.9 ± 29.2 µg·min
-1
) (Figure 14).  
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No significant main effect for trial (F1, 7 = 0.002, p = 0.969) and time (F2, 14 = 1.262, p = 
0.313) were found between pre- and post-training (Figure 13). The exercise-induced SIgA 
secretion rate (pre- to post-exercise) decreased by 309% from pre- to post-training. A small 
ES between pre- and post-training (0.32) was observed.  
No significant difference (p = 0.058) was found between pre-training, post-training and post-
recovery (Figure 14). The calculated ES for the exercise-induced SIgA secretion rate showed 
a small ES between pre- and post-training (0.4) and a large ES between post-training and 
post-recovery (1.61) and pre-training and post-recovery (1.18). 
 
 
Figure 13 Pre- and post-training average SIgA secretion rate (µg·min
-1
)
 
to the RPEtreadmill bout (n = 8). Values 
are mean ± SD. 
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Figure 14 Pre-training, post-training and post-recovery average SIgA secretion rate (µg·min
-1
)
 
to the RPEtreadmill 
bout (n = 4). Values are mean ± SD. 
 
4.9 RESTQ-76 Sport Questionnaire 
Analysis of the RESTQ-76 Sport questionnaires revealed that general stress, general 
recovery, sport stress and sport recovery category scores did not significantly differ from pre- 
to post-training (p > 0.05) (Figure 15). Analysis of individual statements revealed no 
significant differences occurred between the main trials (p > 0.05) other than social relaxation 
was significantly higher post-training compared to pre-training (p = 0.03). A small ES for 
general stress (0.29), sport stress (0.41) and sport recovery (0.29) and a moderate ES for 
general recovery (0.55) between pre- and post-training were observed.  
A significant difference in sport stress (F2, 6 = 6.552, p = 0.031) was found with a t-test 
indicating sport stress decreased from post-training to post-recovery (p = 0.041) (Figure 16). 
No significant differences in general stress (F2, 6 = 4.067, p = 0.077), general recovery (F2, 6 = 
1.131, p = 0.383) and sport recovery (F2, 6 = 0.41, p = 0.365) occurred between pre-training, 
post-training and post-recovery. A large ES for general stress (0.90), general recovery (1.07) 
and sport stress (0.95) between pre- and post-training were observed. A moderate ES for 
general recovery (0.78) and sport stress (0.77) and a large ES for sport recovery (0.82) 
between pre-training and post-recovery were observed.  
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Figure 15 Pre- and post-training RESTQ-76 Sport general stress, general recovery, sport stress and sport 
recovery scores (n = 8). Values are mean ± SD. 
 
 
Figure 16 Pre-training, post-training and post-training RESTQ-76 Sport general stress, general recovery, sport 
stress and sport recovery scores (n = 4). Values are mean ± SD. 
*denotes a significant decrease from post-training to post-recovery (p < 0.05). 
 
4.10 Upper Respiratory Symptoms 
No significant differences between pre- and post-training average URS scores were observed 
(p > 0.05), with the exception of headaches, which were significantly increased from pre- to 
post-training (p = 0.046) (Figure 17). A moderate ES between pre- and post-training (0.75) 
was observed.  
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No significant differences were observed for symptoms associated with URS between pre-
training, post-training and post-recovery (p > 0.05) (Figure 18). The calculated ES for URS 
found a small ES between post-training and post-recovery (0.44) and a moderate ES between 
pre- and post-training (0.51). No ES between pre-training and post-recovery was observed. 
 
Figure 17 Average pre- and post-training upper respiratory symptom (URS) scores (n = 8). Values are mean ± 
SD.  
*denotes a significant increase from pre-training (p < 0.05).  
 
 
Figure 18 Average pre-training, post-training and post-recovery upper respiratory symptom (URS) scores (n = 
4). Values are mean ± SD. 
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4.11 Individual Responses 
From all the participants that completed the study (n = 8), only four participants completed 
the post-recovery main trial. From these four participants, two participants (participants 2 and 
7) have been highlighted as FOR due to showing signs associated with this state (i.e. a 
decrease in 10 km TT performance from pre- to post-training and a super-compensatory 
performance improvement post-recovery which is primary indicator of FOR). No participants 
showed signs of NFOR or OTS.   
 
4.11.1 10 km Time Trial Performance 
Participant 2, 3 and 7 pre-training 10 km TT performance were 45.0 min, 46.2 min and 35.7 
min. Compared to pre-training, participant 2, 3 and 7 post-training 10 km TT performance 
were 18%, 3% and 12% slower (participant 2: 53.2 min; participant 3: 47.5 min; participant 
7: 40.0 min). Participant 2 and 7 post-recovery 10 km TT performance were 8% and 5% 
quicker compared to pre-training and 22% and 15% quicker compared to post-training 
(participant 2: 41.5 min; participant 7: 34.0 min). Participant 3 post-recovery 10 km TT 
performances were 2% slower compared to pre-training and 1% quicker compared to post-
training. Individual 10 km TT performances are presented in Figure 19. 
 
Figure 19 Individual 10 km time trial performances (min) pre-training, post-training and post-recovery. 
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4.11.2 Salivary Hormone Responses 
Pre-training exercise-induced salivary testosterone response (pre- to post-exercise) decreased 
by 17% in participant 1 and increased by 67%, 41% and 49% in participant 2, 3 and 7. 
Compared to pre-training, post-training exercise-induced response increased by 268% in 
participant 1, decreased by 93% and 144% in participant 2 and 7 and did not change in 
participant 3. Individual exercise-induced salivary testosterone responses are presented in 
Figure 20. 
Pre-training exercise-induced salivary cortisol response (pre- to post-exercise) increased by 
12%, 50% and 82% in participant 1, 2 and 3 and decreased by 30% in participant 7. 
Compared to pre-training, post-training exercise-induced response increased by 50% and 
244% in participant 1 and 3 and decreased by 100% and 20% in participant 3 and 7. 
Individual exercise-induced salivary cortisol responses are presented in Figure 21. 
 
 
Figure 20 Absolute change of the individual exercise-induced salivary testosterone responses (pmol·L
-1
)
 
to the 
RPEtreadmill bout pre-training, post-training and post-recovery. 
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Figure 21 Absolute change of the individual exercise-induced salivary cortisol responses (nmol·L
-1
)
 
to the 
RPEtreadmill bout pre-training, post-training and post-recovery.  
 
4.11.3 Salivary Secretory IgA Responses 
Pre-training exercise-induced SIgA concentrations increased by 45% and 66% in participant 
1 and 2 and decreased by 13% and 1% in participant 3 and 7. Compared to pre-training, post-
training exercise-induced response increased by 67%, 33% and 60% in participant 1, 3 and 7 
and decreased by 36% participant 2. Individual exercise-induced SIgA concentrations are 
presented in Figure 22.  
Pre-training exercise-induced SIgA secretion rate increased by 163% and 70% in participant 
1 and 7 and decreased by 1% and 24% in participant 2 and 3. Compared to pre-training, post-
training exercise-induced secretion rate decreased by 140% and 114% in participant 1 and 7 
and increased by 1643% and 146% in participant 2 and 3. Individual exercise-induced SIgA 
secretion rate are presented in Figure 23.  
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Figure 22 Absolute change of the individual exercise-induced SIgA concentrations (mg·L
-1
) to the RPEtreadmill 
bout pre-training, post-training and post-recovery. 
 
 
Figure 23 Absolute change of the individual exercise-induced SIgA secretion rate (µg·min-1) to the RPEtreadmill 
bout pre-training, post-training and post-recovery. 
 
4.11.4 RESTQ-76 Sport Questionnaire 
Participant 1 sport stress scores were 3% lower pre- to post-training and 8% lower post-
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sport stress scores (participant 2: 4.7; participant 3: 4.7; participant 7: 3.0) were 50%, 36% 
and 57% lower compared to post-training and 6%, 30% and 47% lower compared to pre-
training. Individual sport stress scores are presented in Figure 24. 
 
 
Figure 24 Individual RESTQ-76 Sport stress scores. 
 
4.11.5 Upper Respiratory Symptoms 
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headache, malaise and joint aches and pains post-training. No URS were reported post-
recovery. Participant 2 and 3 reported no URS pre-training, post-training and post-recovery. 
Participant 7 reported no URS pre-training but did report mild symptoms of headache and 
malaise and moderate symptoms of nasal discharge and obstruction post-training. Participant 
7 also reported mild symptoms of nasal discharge and obstruction post-recovery. Individual 
URS reported are presented in Figure 25. 
 
0
1
2
3
4
5
6
7
8
9
10
1 2 3 7
R
E
S
T
Q
-7
6
 S
p
o
rt
 s
tr
es
s 
sc
o
re
s 
Participant 
Pre-training
Post-training
Post-recovery
58 
 
 
Figure 25 Individual upper respiratory symptoms (URS) reported pre-training, post-training and post-recovery. 
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CHAPTER 5 Discussion 
5.1 Aims of Study 
The present study aimed to determine if there was any hormonal alteration of cortisol and 
testosterone and mucosal immunological responses of SIgA to a 30 min high-intensity 
running bout (RPEtreadmill) before and after a 12 day intensified training period. More 
specifically, it aimed to establish a reliable biological marker and useful tool that may aid in 
the identification of overreaching (specifically FOR) and therefore the prevention of the OTS 
occurring in athletes. 
 
5.2 Key Findings 
The primary finding of the present study was that the exercise-induced salivary testosterone 
response significantly increased pre-training with no exercise-induced response found post-
training. The exercise-induced salivary cortisol response did not significantly differ from pre- 
to post-training. No significant difference in the 10 km TT performance was found however, 
a small decrease was observed from pre- to post-training (ES = 0.24). Moreover, SIgA 
concentrations and secretion rate did not significantly differ between pre- and post-training. 
Although, the calculated ES showed that a small decrease in secretion rate did occur post-
training (ES = 0.32). Analysis of the four participants who completed all three main trials 
showed that the exercise-induced salivary testosterone, cortisol and SIgA concentrations and 
secretion rates did not significantly differ between pre-training, post-training and post-
recovery. However, the calculated ES for salivary testosterone showed that compared to pre-
training, a moderate decrease occurred post-training (ES = 0.67) and a large increase 
occurred post-recovery (ES = 1.07). Individual analysis of all four participants that completed 
all main trials showed indications of participant 2 and 7 being in a FOR state due to a 
decrease in 10 km TT performance post-training compared to pre-training with a super-
compensatory performance increase post-recovery. This was supported by a decrease in the 
exercise-induced salivary testosterone response and sport stress scores post-training 
compared to pre-training.  
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5.3 10 km Time Trial Performance 
A hallmark feature of overreaching and the OTS is the decrease in sport-specific performance 
due to inability to sustain the exercise intensity during increases in training load (Urhausen, 
Gabriel and Kindermann, 1995; Meeusen et al., 2004). With this being a primary indicator of 
overreaching, the 12 day intensified training period did have an impact on the participant’s 
performance. As illustrated in Figure 5, the TTC pre-training was 45.2 ± 5.3 min and post-
training 46.4 ± 4.7 min. Although the 10 km TT performance did not significantly differ from 
pre- to post-training, a small ES (0.24) was observed with a performance decrease of 3%. 
This may only be a small decrease but it is an important finding for trained athletes as this 
would highlight a meaningful reduction in their performance. Furthermore, it suggests that 
the 118% increase in training load over a 12 day period induced early stages of overreaching 
(specifically FOR). Previous studies have also reported a decline in performance of similar 
magnitude reported in the present study (Jeukendrup et al., 1992; Snyder et al., 1995; 
Meeusen et al., 2004). Jeukendrup et al. (1992) reported a 3-4% decrease in maximal aerobic 
power during a graded incremental test to exhaustion as well as a 5% decrease in an 8.5 km 
TT performance on a cycle ergometer following a 2 week period of intensified training. 
Moreover, Meeusen and colleagues observed decreases in cycling performance (time to 
voluntary exhaustion) following a 10 day training camp. Specifically, they found a 6% 
decrease in overreached athletes and an 11% decrease in OTS athletes. 
There is further evidence to suggest that the participants in the present study were induced 
into an overreached state (specifically FOR) as seen in the four participants who completed 
all three main trials. Although one participant was removed (participant 1) from the data 
analysis due to not completing the post-training 10 km TT, average performances decreased 
from pre- to post-training and a super-compensatory effect occurred post-recovery. It should 
be noted that a large SD for all trials occurred due to only a small number of participants (n = 
3) completing the all three main trials and a large variation between each participants TTC. 
Although no significant differences were found between all three trials, ES show that a 
moderate decrease from pre- to post-training (0.76) and a large increase from post-training to 
post-recovery (0.89) occurred. The calculated ES highlight that the changes that occur in 
performances following a 12 day intensified training period and 4 day recovery period. 
Furthermore, TTC results show that participants were able to recover sufficiently following a 
4 day recovery period. Previous studies have suggested that well-trained runners need a 
minimum of 48 h to fully recover from a 10 km race (Gómez et al., 2002). 
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Further analysis of individual 10 km TT performances have highlighted that participant 2 and 
7 both showed similar responses over the duration of the study which indicate signs of being 
in a FOR state. As a group, overreaching could not be confirmed and therefore participant 2 
and 7 were selected for individual analysis due to many of their responses being associated 
with FOR, for example, a decrease in 10 km TT performance and a blunted hormone 
(testosterone) response. Participant 2 and 7 10 km TT performances were slower pre- 
(participant 2: 45.0 min; participant 7: 35.7 min) to post-training (participant 2: 53.2 min; 
participant 7: 40.0 min) and performances were super-compensatory following a 4 day 
recovery period (participant 2: 41.5 min; participant 7: 34.0 min). This is an indication of 
both participants being in an FOR state due to post-recovery performance levels increasing 
beyond pre- and post-training levels. It should be noted that the variation in TTC due to 
different level of athletes recruited for this study could have an influence on the results. 
Athletes who were more accustomed to the heavy training load are more likely to cope with 
feelings of fatigue better compared to recreational athletes. This could lead to larger 
variations in post-training 10 km TT performances as observed in participant 2 and 7.  
  
5.4 Salivary Testosterone Response 
The exercise-induced salivary testosterone response increased significantly by 36% during 
the pre-training main trial highlighting the capability of the RPEtreadmill to induce robust 
elevations in salivary testosterone when in a normal trained state. This supports the findings 
of previous work conducted in the University of Bedfordshire’s laboratories which was 
reported that this exercise-induced response is reproducible (Leal, 2017). This finding is also 
in agreement with Hough et al. (2011) and Hough et al. (2013) who reported comparable 
findings in which salivary testosterone were shown to elevate to a protocol of a similar 
exercise intensity but with a different mode of exercise (a continuous 30 min high-intensity 
cycling bout referred to as the 55/80) when individuals were in a normal trained state. 
Furthermore, previous studies have shown that an exercise-induced increase when in a 
normal trained state is important to highlight any alterations that occur during periods of 
intensified training (Hough et al., 2011, 2013). Therefore, the importance of the RPEtreadmill to 
induce a significant elevation in salivary testosterone in this study and previous studies is 
essential to the detection of overreaching. This would help highlight any blunting response 
which would occur if an athlete was in an overreached state.  
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The exercise-induced salivary testosterone response did not significantly differ between pre- 
and post-training, however a significant increase in this variable was found when examined in 
the pre-training main trial. This could suggest initial stages of a blunted response of salivary 
testosterone following the 12 day intensified training period. Following the 12 day intensified 
training period, the exercise-induced salivary testosterone response decreased by 42% when 
compared to pre-training responses. This is supported by a small ES between pre- and post-
training (0.43) which highlights a meaningful reduction between trials. A possible 
explanation for the initial stages of a blunted salivary testosterone response following an 
intensified training period could be due to repeated exposure to individual exercise sessions 
on a daily basis which may have resulted in elevations in cortisol production. It has been 
suggested that high levels of cortisol may negatively impact upon the testosterone response 
by disrupting the testicular testosterone biosynthesis pathway (Cumming, Quigley and Yen, 
1983). However, blood samples were not collected to confirm whether there was an 
interaction between these hormones to confirm this theory. This finding is in agreement with 
previous literature (Hough et al., 2013; Hough, Robertson and Gleeson, 2015). Previous 
studies have shown the exercise-induced salivary testosterone response to decrease by 44% in 
a group of elite triathletes following a 10 day intensified training period (Hough, Robertson 
and Gleeson, 2015) and decrease by 21% in physically active males following a 11 day 
intensified training period (Hough et al., 2013). The reductions found in these studies are 
similar to the finding in the present study suggesting that the athletes showing indications of a 
blunted testosterone response following periods of intensified training could be a potential 
biological marker for those in the initial stages of overreaching.  
It was also hypothesised that the exercise-induced salivary testosterone response would return 
to, or increase above pre-training levels following a 4 day recovery period. No significant 
differences were observed between pre-training, post-training and post-recovery. However, 
ES show a moderate decrease in the exercise-induced salivary testosterone response from 
pre- to post-training and large increases from post-training to post-recovery and pre-training 
to post-recovery. These findings support hypothesis four. Further evidence of the participants 
showing indications of a blunted exercise-induced salivary testosterone response is supported 
by the individual responses found in participants 2 and 7. Firstly, both participants salivary 
testosterone response pre-training elevated by 67% (participant 2) and 49% (participant 7) in 
response to the RPEtreadmill bout which is important to highlight any alterations in an 
overreached state. Following the 12 day intensified training, both participants showed 
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decreases of 93% and 144% in the exercise-induced salivary testosterone response. This 
finding supports the view that participant 2 and 7 were in an overreached state. With the 
primary indicator for overreaching being a decrease in performance which was observed in 
both participants, the blunted exercise-induced salivary testosterone response may be a 
biological indicator of overreaching. Furthermore, the post-recovery exercise-induced 
salivary testosterone responses returned to pre-training levels and therefore it can be 
specifically viewed as both participants were in an FOR state. This is supported by the post-
recovery 10 km TT performance being quicker and sport stress scores decreasing compared 
to post-training. This supports the view that these two participants are overreached as this 
highlights a super-compensatory response in the exercise performance which is key feature of 
FOR (Meeusen et al., 2013).  
  
5.5 Salivary Cortisol Response 
An unexpected finding from this study was that the exercise-induced salivary cortisol 
response did not significantly differ from pre- to post-training which is contradictory to 
hypothesis one. Although no significant differences occurred, a small increase was observed 
for the exercise-induced salivary cortisol response between pre- to post-training (ES = 0.49) 
with an increase of 675%. It was also hypothesised that the RPEtreadmill would induce an 
elevation in the salivary cortisol response pre-training when participants were in a normal 
trained state. Thereafter, a blunted response to the RPEtreadmill post-training would occur. 
However, as illustrated in Figure 9, the RPEtreadmill bout failed to induce a significant 
elevation in cortisol pre-training which is necessary to highlight any alterations which may 
occur as a result of overreaching (Hough et al., 2011, 2013). Previous studies which have 
examined the effects of intensified training periods on the exercise-induced hormone 
response have found cortisol to decrease (Meeusen et al., 2004; Hough et al., 2013). Hough 
et al. (2013) reported a 166% decrease in the exercise-induced salivary cortisol response 
following an 11 day intensified training period. Moreover, Meeusen et al. (2004) found a 
blunted cortisol response to the second test of a two-bout maximal exercise protocol 
following a 10 day intensified training period. A possible explanation for this finding found 
in the present study could be due to unaltered RESTQ-76 Sport questionnaire scores from 
pre- to post-training which suggests that the participants were able to cope with the increase 
in training load. This explanation was also suggested by Hough, Robertson and Gleeson 
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(2015) who also found the exercise-induced salivary cortisol response to be unaltered 
following a 10 day intensified training camp in elite male triathletes. Another possible 
explanation could be that the RPEtreadmill bout may not have been stressful enough to induce a 
significant elevation and could suggest that cortisol may not be sensitive enough to indicate 
an increase in training load. 
No significant differences were found across all trials (Figure 10), however small to large ES 
were observed which suggests that a difference between trials did occur. It was hypothesised 
a blunted response would occur following a 12 day intensified training period and thereafter 
salivary cortisol responses would return to, or increase above pre-training levels following a 4 
day recovery period. However, contrary to this hypothesis, the ES show that compared to pre-
training, cortisol responses increased by small magnitude (0.4) post-training and increased by 
a large magnitude post-recovery (0.92). The small to large increases found could be due to 
the large variation in individual responses to the RPEtreadmill bout (Figure 21). Analysis of 
participant 2 and 7 who have been identified as being in a state of FOR also suggests that 
cortisol may not be most reliable marker of overreaching. The RPEtreadmill did not increase the 
salivary cortisol response in participant 7 when in a normal trained state. In contrast, 
participant 2 did have exercise-induced increase pre-training and a 100% blunted response 
post-training. As seen with these two participants, cortisol does seem to produce variable 
results and it does suggest that salivary testosterone may be the more sensitive marker 
(compared to cortisol) to an elevation of exercise training stress. This finding is in agreement 
with Hough, Robertson and Gleeson (2015) findings. 
  
5.6 Salivary Secretory IgA Response 
In the present study, SIgA was expressed as absolute concentration and secretion rate. 
Furthermore, this study examined the resting and exercise-induced responses to the 
RPEtreadmill bout. Expressing SIgA as two different methods produced varying results. Firstly, 
the resting SIgA absolute concentrations did not significantly differ from pre- to post-
training. However, when analysing the four participants which completed the additional post-
recovery main trial, a significant decrease from pre- to post-training was observed. This 
finding is in agreement with previous literature which has reported resting SIgA absolute 
concentrations to decrease following a period of intensified training (Tharp and Barnes, 1990; 
Robson et al., 1999; Gleeson et al., 2002; Fahlman and Engels, 2005; Neville, Gleeson and 
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Folland, 2008). However, this finding may be solely due to the low number of participants 
which completed all three trials. Direct comparison with some of these studies is difficult due 
to being conducted over a longer duration (i.e. competitive season) compared to the present 
study. In comparison to this study, many of these studies have only observed resting SIgA 
absolute concentrations in response to an athlete’s normal training throughout a season and 
have not intentionally increased the athlete’s training load to induce a state of overreaching. 
However, some studies of a similar nature have shown resting SIgA absolute concentrations 
to decline following a period of intensified training (Robson et al., 1999; Gleeson et al., 
2002). Gleeson et al. (2002) reported a reduction in resting SIgA absolute concentrations 
following a 30 day intensified training period in elite swimmers. Other studies have showed 
resting SIgA absolute concentrations to decrease in military cadets following a 5 day combat 
course (Tiollier et al., 2005) and in Australian Air Force pilots following a 19 day survival 
course (Carins and Booth, 2002). However, other stressors (i.e. psychological stress, hunger 
and sleep deprivation) were induced within these studies and together with the intensified 
training would have likely contributed to the reduction in SIgA reported in these studies. 
Moreover, the present study investigated the exercise-induced SIgA concentrations and 
secretion rate to the RPEtreadmill bout. It was hypothesised that an exercise-induced SIgA 
response to the RPEtreadmill bout would occur and thereafter, a blunted response would result 
following a 12 day intensified training period. The findings revealed that SIgA concentrations 
and secretion rate was unaffected by the exercise and training which is contrary to hypothesis 
two. Although the RPEtreadmill failed to induce a significant elevation, the exercise-induced 
SIgA secretion rate did decrease by 309% from pre- to post-training. This decrease is 
supported by the calculated ES which revealed that a small decline (ES = 0.32) occurred for 
secretion rate. Although this may only represent a small effect, it does highlight that the 
periods of intensified training have an impact on mucosal immunity. A limited number of 
studies have investigated the effects of periods of intensified training on the exercise-induced 
SIgA responses, specifically in response to short-duration, high-intensity exercise. Studies 
which have, have done so over a 7 month period in response to individual swimming sessions 
lasting longer than 1.5 h (Gleeson et al., 1995). Studies which have investigated the effect of 
short-duration, high-intensity exercise on the SIgA responses have shown secretion rates to 
increase post-exercise (Blannin et al., 1998; Allgrove et al., 2008). Allgrove and colleagues 
reported SIgA secretion rates to increase following an incremental test to exhaustion and 
Blannin and colleagues reported SIgA absolute concentrations and secretion rates to increase 
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following a cycle to exhaustion (~37 min) at 80% V̇O2max. These studies highlight that SIgA 
is elevated to high-intensity exercise which was not found in the present study. A possible 
explanation for this could be due to the different protocols used in this study. The RPEtreadmill 
consisted of alternating blocks of 1 min at 11 RPE and 4 min at 15 RPE and when calculated 
was equal to ~67% V̇O2max which may not have been intense enough to induce significant 
elevations in SIgA. Previous studies have used an exercise protocol where participants 
sustain a higher exercise intensity (Blannin et al., 1998; Allgrove et al., 2008). For example, 
Blannin et al. (1999) exercise protocol was a cycle to exhaustion at 80% V̇O2max(~37 min) 
and Allgrove et al. (2008) was maximal incremental cycle test to exhaustion (~22 min).  
It has been suggested that during periods of intensified training, athletes experience illnesses 
more frequently and therefore SIgA could be used as a marker of overreaching to predict the 
occurrence of URS (Nieman, 2003). Specifically, the secretion rate of SIgA has been 
suggested as a unique predictor of URS (Fahlman and Engels, 2005). The present study did 
not find any significant differences in URS between the pre- and post-training other than 
headaches were significantly higher from pre- to post-training. However, moderate ES were 
found between pre- and post-training. This highlights the impact of the 12 day intensified 
training period on the participants which could suggest that chronic exercise impairs mucosal 
immunity leading to an increase in illnesses. With this said, the SIgA secretion rate which 
declined post-training by 309% may have contributed to the increase in URS.  However, 
understanding the causes of the increased occurrence of URS post-training is still unknown as 
no significant differences were found in the exercise-induced concentrations and secretion 
rates between pre- and post-training which contradicts the hypothesis previously proposed in 
this study. Furthermore, the four participants that completed all three main trials did not have 
any significant differences in their URS scores. As previously mentioned, a small sample size 
could have attributed to this. In addition, potential explanation for this finding could be due to 
the number of days it takes for URS to appear following exposure and therefore alterations in 
SIgA may not have been present in the whole group. It has been suggested that the incubation 
period of URS is usually 1 to 3 days (Department of Health CDCB, 2005).  
As overreaching could not be confirmed as whole group, participant 2 and 7 have been 
highlighted as being in FOR state. Therefore, it is expected that the a decrease in SIgA and 
the occurrence of URS is more frequent in overreached athletes (Nieman, 2003). Examining 
these participants individually could help provide better clarification of the occurrence of 
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URS in an overreached state. However, the number of URS reported varied between 
participant 2 and 7. Participant 2 reported no URS pre-training, post-training and post-
recovery whereas participant 7 reported four URS post-training (mild to moderate symptoms) 
and none pre-training and post-recovery. It is possible that the increase in URS reported from 
participant may have been due to the 114% decrease in exercise-induced SIgA secretion rate. 
Previous studies have found SIgA responses to be consistently lower by 18-32% in stale 
athletes and possibly predisposed to OTS over a 6 month competitive season (Mackinnon and 
Hooper, 1994). However, it cannot be concluded whether the lowering of SIgA secretion rate 
was responsible for increased URS in participant 7 because SIgA concentrations were 
increased post-training by 60%. It is clear from the whole group data and the individual data 
that more research needs to be conducted on the exercise-induced SIgA responses and its 
response following periods of intensified training.  
 
5.7 Applications of Findings 
The present study aimed to establish a useful tool which would highlight any blunted salivary 
cortisol and testosterone response which would aid in the identification of overreaching 
(specifically NFOR). The findings of this study suggest that the RPEtreadmill bout could be a 
useful tool in highlighting the initial stages of any alterations in salivary testosterone 
following a period of intensified training. Therefore, the RPEtreadmill bout could be useful for 
athletes and coaches to help diagnose and prevent the occurrence of overreaching and also 
monitor training loads to successfully achieve optimal performance. Specifically, the 
RPEtreadmill bout provides as a more practical and alternative test for runners to use compared 
to the cycling tests used in Hough et al. (2013), Hough, Robertson and Gleeson (2015) and 
Meeusen et al. (2004). Furthermore, the advantage of RPEtreadmill is its usability in the field 
(i.e. athletics track) which makes it easy for athletes/coaches to incorporate into their training 
programmes. The RPEtreadmill test is feasible for athletes/coaches to use as it can be performed 
without the need for any specialist equipment or knowledge. The simplicity of using a Borg 
scale means exercise intensity of the test can be easily determined as it is down to the 
individual’s own perception of exertion and therefore there is no need for preliminary testing.  
Another finding of this study suggests that salivary cortisol may not be a useful marker in the 
identification of overreaching. In comparison to testosterone, the RPEtreadmill bout failed to 
induce a significant cortisol elevation pre-training which is required to identify any alteration 
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in this hormone to occur post-training. This could be due to the intensity of the RPEtreadmill 
bout not being high enough and therefore future research should consider increasing the 
intensity of this bout to induce a significant elevation. This would provide better 
understanding of salivary cortisol as a marker of overreaching.  
Furthermore, the 12 day intensified training period implemented in this study aimed to induce 
a state of overreaching in these athletes but was not sufficient enough to cause overreaching. 
As a whole group overreaching could not be confirmed and as highlighted from the 
individual data, only two participants showed markers which were consistent with 
overreaching. Although, overreaching could not be confirmed as a whole group, increasing 
the training load did show to have impact on the individual’s performance. This is important 
for coaches to consider when increasing an athlete’s training load.  
 
5.8 Limitations and Future Research 
One of the limitations of the present study is the use of the Jackson Score URS questionnaire. 
Although its use is not a limitation itself as it has been validated against pathogen 
identification methods and it is regarded as a reliable tool to use in exercise studies (Bermon 
et al., 2017). But better clarity is needed to understand the impact of an intensified training 
period on mucosal immune system. Therefore, future research should aim to include regular 
clinical assessments throughout the study to provide better clarity on URS and other causes of 
URS (i.e. beyond infection). 
The small number of participants recruited for this study resulted in a low power outcome 
from the post-hoc power analysis which is a limitation of the study. However, due to the 
nature of the study design, the completion of eight participants requires much work. In 
addition, the small number of participants that completed the post-recovery main trial was 
also a limitation. Due to high drop-outs and certain complications throughout the study, some 
individuals were not able to complete this trial and therefore a true comparison of results 
between all three main trials was difficult. Future research should aim to increase the number 
of participants which may provide a better understanding of hormonal and immunological 
responses following a recovery period after completing a 12 day intensified training period. 
Furthermore, another limitation to consider is not measuring for blood contamination of 
saliva samples in cortisol and testosterone. The detection of blood contamination in SIgA is 
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not relevant as blood IgA is monomeric. It has been suggested that blood leakage into saliva 
can occur from accidental injuries, poor oral health or some infectious diseases (Kamodyová 
et al., 2015; Brescia et al., 2016). Therefore, blood leakage into saliva from the oral mucosa 
could result in compromised salivary hormone values (Malamud and Tabek, 1993). Future 
research should aim to reduce the likelihood of this occurring by including a blood 
contamination measurement of salivary samples into the salivary handling and collection 
process. One approach would be to systematically inspect each saliva sample at the moment 
of collection and if any traces of blood are visible to the naked eye should be excluded from 
the analysis (Brescia et al., 2016). 
 
5.9 Conclusion 
Overall, the present study demonstrated that the RPEtreadmill significantly induces robust 
elevations in salivary testosterone when in a normal trained state and therefore this exercise 
protocol could be used to highlight any alterations when in an overreached state. No 
significant exercise-induced salivary testosterone response occurred post-training suggesting 
that the initial stages of a blunted salivary testosterone response occurs following a 12 day 
intensified training period. Therefore, the RPEtreadmill bout could be used as a tool for athletes 
(specifically runners) and coaches to identify the alterations in salivary testosterone to help 
diagnose and prevent overreaching in athletes. Moreover, the 10 km TT performance 
decreased from pre- to post-training which is an important marker to use when diagnosing 
athletes as overreached. The exercise-induced absolute concentrations and secretion rate of 
SIgA did not significantly differ following a 12 day intensified training period. However, the 
small ES for secretion rate does provide some evidence of mucosal immunity to be inhibited. 
Therefore, it can be concluded that the 12 day intensified training period may have only 
induced a state of overreaching in some participants and not in all of them. Participant 2 and 
7 were individually analysed and were identified as being in an FOR state. A decrease in 10 
km TT performance and super-compensatory improvement was the primary indicator of this 
and it was coupled with a blunted salivary testosterone response and sport stress scores. 
These are all important markers which have been reported in athletes diagnosed as 
overreached (Meeusen et al., 2013).  
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Appendices 
 
Appendix A 
 
Participant Information Sheet 
 
Study Title: 
Exercise-induced salivary hormones and immunological responses before and after a 12-day period 
of intensified-training: preventing the incidence of non-functional overreaching / the overtraining 
syndrome 
 
Dear participant, 
Thank you for showing an interest in taking part in this research study. Please, read this information 
sheet carefully before deciding whether to participate. If you freely decide to volunteer you are more 
than welcome and we thank you for your participation. If you decide not to take part there will be no 
disadvantage to you of any kind and we thank you for considering our request. Nevertheless, if you 
wish at any stage to withdraw from the study there will be no reprisal. Every precaution will be taken 
to protect the privacy of all the participants and data confidentiality and anonymity will be preserved. 
 
What is the aim of the project? 
The purpose of the study is to analyse whether a 12-day period of intensified training may induce a 
state of overreaching, and to also examine the exercise-induced stress hormone and immune 
responses to a short-duration, self-paced running bout before and after this 12-day intensified-training 
period. The use of this exercise tool may be a good method to predict and/or prevent the incidence of 
overreaching or the overtraining syndrome (OTS), and may be used in any sports-related setting. 
Additionally, it is intended to examine whether a 4-day recovery period would be enough to normalize 
any training-related symptoms of maladaptation. 
 
What kind of participants are needed? 
We are seeking to recruit physically active, healthy male volunteers aged between 18-35 years old 
who exercise at least three times per week. Participants must not be smokers, alcoholic or night-shift 
workers. 
 
Is it safe for you to participate in the study? 
Prior to any kind of participation in the study, you will be asked to complete a physical activity 
readiness questionnaire (PAR-Q) and a blood screening analysis questionnaire. 
 
What will be asked of participants? 
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Once you accept to participate in this study you will be requested to follow the following: 
 18 laboratory sessions in total – 2 maximal oxygen uptake (VO2max) tests, 4 10-km time-trials, 4 
short-duration (30-min) running trials, and a 12-day period of intensified, imposed training 
followed by a 4-day recovery observational period. 
 
Before every trial, excluding the ones completed during the 12-day training period: 
 500mL of water in the morning prior to each session; 
 Standard breakfast that you would like to reproduce (4h before main trials); 
 Fasted state from breakfast to main exercise trial; 
 No alcohol, caffeine and exercise (24h leading up to testing); 
 You will be required to be in the laboratory at 11:30am; 
 Blood and saliva samples collected at 3 time points (on 3 different trials); 
 Urine sample for hydration analysis. 
 
Detailed description of what you will be asked to do in each session is described below: 
 
Prior to intervention you will be familiarized with the laboratory environment and research team. You 
will have the opportunity to continue asking any questions about the experimental process throughout 
the time of the project. 
 
On the main exercise trials you will be asked to complete a short-duration, self-paced treadmill-
running bout (RPEtreadmill). The RPEtreadmill consists of a continuous 30-min treadmill-run, alternating 
blocks of 1 min and 4 min at a speed that will elicit a low and a high perceived exertion, respectively. 
You will be asked to alter the speed as you wish during the test, in order to maintain your perceived 
exertion within the required range. 
 
After completing this test, you will be allowed a 1-hour recovery period, followed by a 10-km time-trial. 
The day after, you will be required to undertake a maximal fitness test where you will be required to 
exercise to volitional exhaustion, which will happen on the day before the start of the 12-day training 
period. During the 12-day period of training, you will be required to come to the labs every day to 
complete one of three different exercise protocols. Protocols will be interposed so you do not 
complete the same exercise protocol on two consecutive days, and will be designed as follows: a) a 
90-min continuous treadmill-run, subdivided in one block of 70 min at 55% of your maximal speed in 
the maximal fitness test and one 20-min block at 75% of that same maximal speed; b) a 5-km time-
trial; c) a 70-min, self-paced, continuous treadmill-run at a speed corresponding to a rating of 
perceived exertion (RPE) of 12 (light) on the 6-20 Borg scale for the first 30 min, at 13 (somewhat 
hard) during the following 30 min, and at 15 (hard) for the final 10 min. Each session will be 
completed 3 times in total over the 12-day period. This training program will be classified as an 
intensification of your normal training sessions. 
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After the training period, you will be asked to complete the set of tests again, which will be repeated 
one final time 4 days after the end of the 12-day training period. 
 
During the whole study, you will have to follow a training diary, which will be handed out to you. On 
each training session outside the labs, you will use a heart rate (HR) monitor and be asked to record 
resting HR, maximal HR during exercise, and average HR of the session. In the 24 h before each 
RPEtreadmill test you will also have to complete a food intake diary, which will also be provided. You will 
be given a food scale so you can weigh your food and replicate it on the two following occasions 
completing the RPEtreadmill. 
 
Overall procedures: 
Trial 1: Oral and practical familiarization with protocols by completing the RPEtreadmill and a 10-km 
time-trial. 
Trial 2 (food diary the day before): Completion of the RPEtreadmill and 10-km time-trial. 
- the day after (~24 hours) 
Trial 3: Completion of a submax and a maximal fitness test on a motorized treadmill. 
- the day after (~24 hours) 
Trials 4-15 (12-day training period): Completion of the exercise protocols a), b) and c) as described 
above. 
- the day after (~24 hours) 
Trial 16 (food diary the day before): Completion of the RPEtreadmill and a 10-km time-trial. 
- the day after (~24 hours) 
Trial 17: Completion of a submax and a maximal fitness test on a motorized treadmill. 
- 4-day recovery period 
Trial 18 (FINAL) (food diary the day before): Completion of the RPEtreadmill and a 10-km time-trial. 
 
What are the possible risks of taking part in the study? 
When completing the maximal fitness test and the RPEtreadmill tests it will be required high-intensity 
exercise and so some discomfort may occur. A certified first-aider will be present during all testing. A 
warm-up will be undertaken each time, in order to reduce the chances of muscular and joint injury. 
 
Blood and saliva samples will be collected by a trained researcher in a clean, quiet environment and 
the experimenter will make sure you feel comfortable enough to do it. During the time-trial and the 
training period, you will be required to run for a relatively long period of time, which may bring you 
some discomfort, and a researcher and a first-aider will be present throughout. 
 
What if you decide you would like to withdraw from the study? 
There will be no disadvantage or reprisal if at any stage you decide you want to stop testing and 
withdraw from the project. The research team will always thank you for any participation you have. 
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What will happen to data collection and information collected? 
Each subject participating in the study may receive a summary of the findings and their own results 
for the tests undertaken if they so wish. Also, all data/information/results will be held securely at the 
University of Bedfordshire and will only be accessible to related University staff. Results of this study 
are intended to be published, but no data will be linked to any specific individuals’ information. 
 
What if you have any questions? 
Questions are more than welcome and I am happy to answer any queries you may have about the 
study at any time. Also Dr John Hough will readily respond to any questions you have. So, you should 
feel free to ask us whatever you need to. 
Should you want to participate in this study, please contact me (see details below for specific contact 
details). You will then be asked to complete the consent form, necessary to take part in the study. 
This project has been reviewed and approved by the University of Bedfordshire Ethics Committee. 
 
 
Diogo Leal, MSc (Lead Researcher)   Michael Harrison, BSc 
Email: diogo.leal@study.beds.ac.uk  Email: michael.harrison@study.beds.ac.uk 
Office phone: 01234 793053    Office phone: 01234 793053  
Dr John Hough, PhD (Supervisor) 
Email: john.hough@beds.ac.uk 
Office phone: 01234 79318  
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Appendix B 
University of Bedfordshire 
Consent form 
To be completed by the participant:  
Name:……………………………………............................... Date: …./…./…….. 
I confirm that I have read the Information Sheet concerning this project and understand what is 
required of me as a participant. I further confirm that my health is normal and the information given 
on the Physical Activity Readiness-Questionnaire (PAR-Q) and on the blood screening analysis form 
is accurate and complete. All my further questions have been answered to my satisfaction. I 
understand that I am free to request further information at any stage. 
 
I know that: 
✓ My participation in the project is entirely voluntary and I am free to withdraw from the 
project at any time without disadvantage or prejudice; 
✓ I will be required to attend 17 sessions to complete the project; 
✓ As part of the study I will have to: 
▪ Complete a training diary on every training session outside the labs; 
▪ Complete a 24-hour food diary on 3 different days; 
▪ Abstain from alcohol, caffeine and exercise on the 24 hours preceding the 
exercise tests (excluding the 12-day period of training); 
▪ Have 3 blood and 3 saliva samples collected by venepuncture and 
unstimulated passive drool, respectively, on 3 different trials; 
▪ Complete an exercise test to exhaustion (i.e. VO2max test) on 2 different occasions; 
▪ Complete a 30-min, high-intensity running bout on 4 different occasions; 
▪ Complete a 10-km time-trial on 4 different occasions; 
▪ Wear a heart rate monitor on each training session; 
▪ Carefully use a kitchen scale provided by the researcher and return it on the last 
day of the study; 
▪ Complete a 77-statement, recovery-stress questionnaire on 4 different days; 
▪ Undertake a consecutive 12-day period of intensified training and a 4-day 
recovery (no exercise) period. 
 
✓ I am aware of any risks that may be involved with the project; 
✓ I was informed that all information and data collected will be held securely at the 
University indefinitely. The results of the study may be published but my anonymity will 
be preserved. 
 
My agreement to participate in the experiment is made of my own free will, and not in response to 
financial or other inducements (e.g. peer pressure). I confirm that I am not currently 
participating in an experimental trial. 
The attention of volunteers is drawn to the fact that in the case of injury to persons or damage to 
property no claim for damages can succeed against University of Bedfordshire or against its 
employees unless legal liability resulting from negligence can be proved. 
 
 
Signature:………………………………………(Participant) Date: ……………  
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Appendix C 
 
Physical Activity readiness questionnaire (PAR-Q) 
 
Please circle the correct answer: 
 
1. Have you ever been told by your doctor that you have a heart condition and advised only 
to participate in physical activity approved by your doctor? 
 
Yes / No 
 
2. Do you experience any chest pains when you participate in physical activity? 
 
Yes / No 
 
3. Have you recently experienced any chest pains whilst not participating in physical activity? 
 
Yes / No 
 
4. Do you ever lose consciousness? 
 
Yes / No 
 
 
5. Do you ever lose your balance as a result of dizziness? 
 
Yes / No 
 
6. Do you have any problems with your bones and joints that could cause further problems if 
you participate in physical activity? 
 
Yes / No 
 
 
7. Are you aware of any reasons as to why you should not participate in physical activity? 
 
Yes / No 
 
Name: .................................…………………………. 
Signature: ........................................  Date: …./…./……..  
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Appendix D 
 
 
University of Bedfordshire 
Health-related daily routine questionnaire 
 
 
To be completed by the participant: 
 
 
Name:……………………………………............................... Date:…./…./…….. 
 
 
Please read the following carefully and answer as accurately as possible. Your 
answers will be treated as strictly confidential. If you have any doubts or 
difficulties with any of the questions please feel free to ask the researcher 
responsible for the study. 
 
 
 
Are you asthmatic? 
 
 
Do you have any allergies (ex. Hay Fever)? 
 
 
In your regular daily routine: 
 
Do you smoke? 
 
 
Do you drink alcohol? 
 
 
You consider your diet is… 
 
 
Hours of sleep? 
 
 
 
 
Thank you very much! 
 
 
 
The Researcher:     / /  
 
The Participant:    
  
Daily Occasionally Never 
Balanced Unhealthy Specific 
Daily Occasionally Never 
Below 5 5-7 hours Above 7 
Yes No 
Yes No 
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Appendix F 
 
JACKSON SCORE UPPER RESPIRATORY TRACT ILLNESS QUESTIONNAIRE 
Name ...............................................    Subject Number….  Date… 
Trial… 
 
Do you think that you are suffering from a common cold or flu today?   
Fill in the circle if your answer is YES o 
 
If yes please complete all the questions below-   
Are any of the following symptoms of the common cold or flu present today? Please 
indicate your response by filling in one circle for each of the following symptoms: 
 
 
SYMPTOM         DEGREE OF DISCOMFORT            
 
        None at all  Mild     Moderate   Severe
         
Sneezing        o  o  o  o           
 
Headache    o  o  o  o            
 
Malaise    o  o  o  o 
(feeling of being generally unwell,  
 run down or out of sorts) 
Nasal discharge   o  o  o  o            
(runny nose) 
 
Nasal obstruction   o  o  o  o  
(blocked nose)            
 
Sore throat    o  o  o  o            
 
Cough     o  o  o  o          
 
Ear ache    o  o  o  o 
 
Hoarseness    o  o  o  o 
 
Fever     o  o  o  o           
 
Chilliness        o  o  o  o            
 
Joint aches and pains  o  o  o  o         
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